STOCK TITAN

BONK flags going-concern doubt with $90.5K cash

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Moderate)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
10-Q

Rhea-AI Filing Summary

BONK, Inc. (BNKK) reported a $10,444,540 consolidated net loss for the nine months ended September 30, 2026, compared with $25,533,204 a year earlier. Sales were $2,271,548 and related-party revenue share was $4,107,694, versus $1,601,865 and $509,085, respectively, in the prior-year period. Operating activities used $4,844,671 of cash, and cash was $90,507 at September 30, 2026, down from $2,278,340 at December 31, 2025.

On September 9, 2026, the company transferred 1,600,001,000,000 BONK tokens, valued at $4,801,536, to lender STS Digital Ltd. as collateral for a $3,000,000 USDC loan. The loan bears no stated interest and matures September 9, 2027. STS may use or rehypothecate the collateral; BONK recorded a $6,064,379 receivable for the return of an equivalent quantity of BONK at September 30, 2026.

The company said its $193,936,719 accumulated deficit, operating cash use and $90,507 cash balance raised substantial doubt about its ability to continue as a going concern. Working capital was $3,944,898 at September 30, 2026.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 1 point

How the balance works

Positive

  • Moderate pointNet loss fell to $10,444,540 from $25,533,204 year over year.
  • Moderate pointRelated-party revenue share reached $4,107,694, versus $509,085 a year earlier.

Negative

  • Major pointSubstantial doubt about continuing as a going concern; quarter-end cash was $90,507.

Filing Explained

By September 30, 2026, Bonk had paid $4,000,000 to repurchase 26,667 Series A preferred shares, which it holds in treasury; Core4 retained 73,333 preferred shares and waived anti-dilution rights.

Sales revenue $2,271,548 Nine months ended September 30, 2026; compared with $1,601,865 in 2025.
Related-party revenue share $4,107,694 Nine months ended September 30, 2026; compared with $509,085 in 2025.
Consolidated net loss $10,444,540 loss Nine months ended September 30, 2026; compared with $25,533,204 loss in 2025.
Net cash used in operating activities ($4,844,671) Nine months ended September 30, 2026.
Cash $90,507 At September 30, 2026; cash was $2,278,340 at December 31, 2025.
STS Digital loan $3,000,000 Received in USDC on September 9, 2026; bears no stated interest and matures September 9, 2027.
BONK collateral fair value $4,801,536 Value of 1,600,001,000,000 BONK tokens transferred to STS Digital on September 9, 2026.
BONK receivable $6,064,379 Fair value at September 30, 2026, for return of an equivalent quantity of BONK.
substantial doubt financial
"raised substantial doubt about the Company’s ability to continue as a going concern"
rehypothecate financial
"STS may use and rehypothecate the Collateral"
fair value option financial
"elected the fair value option under ASC 825-10"
An accounting election that lets a company measure eligible financial assets and liabilities at their current market price, recording gains and losses in the income statement as those prices move. For investors it matters because choosing the fair value option makes reported profits and asset values respond immediately to market swings—like revaluing a house to today’s sale price—so it can increase earnings volatility while giving a more up‑to‑date view of value.
first in first out (FIFO) financial
"accounted for on a first in first out basis (FIFO)"
Level 1 inputs technical
"represent Level 1 inputs within the fair-value hierarchy"
credit collar arrangement financial
"entered into a credit collar arrangement with STS Digital Ltd."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much cash did BNKK report at September 30, 2026?

BNKK reported $90,507 in cash at September 30, 2026. Cash was $2,278,340 at December 31, 2025, and the company used $4,844,671 in operating activities during the nine months ended September 30, 2026.

What was BNKK’s net loss for the first nine months of 2026?

BNKK reported a consolidated net loss of $10,444,540 for the nine months ended September 30, 2026, compared with $25,533,204 for the nine months ended September 30, 2025. Net loss attributable to common stockholders was $11,558,918 in 2026, including a $1,114,378 deemed dividend.

What are the terms of BNKK’s STS Digital loan?

On September 9, 2026, BNKK transferred 1,600,001,000,000 BONK tokens, valued then at $4,801,536, as collateral to STS Digital Ltd. It received a $3,000,000 loan in USDC; the loan bears no stated interest and matures September 9, 2027. STS may use and rehypothecate the collateral.

Why did BNKK disclose substantial doubt about its ability to continue as a going concern?

BNKK said its $193,936,719 accumulated deficit at September 30, 2026, $4,844,671 of cash used in operations over nine months, and $90,507 cash balance raised substantial doubt about continuing as a going concern. The company also reported $3,944,898 in working capital at quarter-end.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false Q3 --12-31 0001760903 Yes Yes 0001760903 2026-01-01 2026-09-30 0001760903 BNKK:CommonStock.001ParValuePerShareMember 2026-01-01 2026-09-30 0001760903 BNKK:WarrantsToPurchaseSharesOfCommonStockMember 2026-01-01 2026-09-30 0001760903 2026-11-16 0001760903 2026-09-30 0001760903 2025-12-31 0001760903 us-gaap:NonrelatedPartyMember 2026-09-30 0001760903 us-gaap:NonrelatedPartyMember 2025-12-31 0001760903 us-gaap:RelatedPartyMember 2026-09-30 0001760903 us-gaap:RelatedPartyMember 2025-12-31 0001760903 2026-07-01 2026-09-30 0001760903 2025-07-01 2025-09-30 0001760903 2025-01-01 2025-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2024-12-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2024-12-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2024-12-31 0001760903 us-gaap:TreasuryStockPreferredMember 2024-12-31 0001760903 us-gaap:CommonStockMember 2024-12-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001760903 BNKK:CommonStockPayableMember 2024-12-31 0001760903 us-gaap:RetainedEarningsMember 2024-12-31 0001760903 2024-12-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-03-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-03-31 0001760903 us-gaap:TreasuryStockPreferredMember 2025-03-31 0001760903 us-gaap:CommonStockMember 2025-03-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001760903 BNKK:CommonStockPayableMember 2025-03-31 0001760903 us-gaap:RetainedEarningsMember 2025-03-31 0001760903 2025-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-06-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-06-30 0001760903 us-gaap:TreasuryStockPreferredMember 2025-06-30 0001760903 us-gaap:CommonStockMember 2025-06-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-06-30 0001760903 BNKK:CommonStockPayableMember 2025-06-30 0001760903 us-gaap:RetainedEarningsMember 2025-06-30 0001760903 2025-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-12-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-12-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-12-31 0001760903 us-gaap:TreasuryStockPreferredMember 2025-12-31 0001760903 us-gaap:CommonStockMember 2025-12-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-12-31 0001760903 BNKK:CommonStockPayableMember 2025-12-31 0001760903 us-gaap:RetainedEarningsMember 2025-12-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-03-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-03-31 0001760903 us-gaap:TreasuryStockPreferredMember 2026-03-31 0001760903 us-gaap:CommonStockMember 2026-03-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001760903 BNKK:CommonStockPayableMember 2026-03-31 0001760903 us-gaap:RetainedEarningsMember 2026-03-31 0001760903 2026-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-06-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-06-30 0001760903 us-gaap:TreasuryStockPreferredMember 2026-06-30 0001760903 us-gaap:CommonStockMember 2026-06-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-06-30 0001760903 BNKK:CommonStockPayableMember 2026-06-30 0001760903 us-gaap:RetainedEarningsMember 2026-06-30 0001760903 2026-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-01-01 2025-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-01-01 2025-03-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-01-01 2025-03-31 0001760903 us-gaap:TreasuryStockPreferredMember 2025-01-01 2025-03-31 0001760903 us-gaap:CommonStockMember 2025-01-01 2025-03-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-01-01 2025-03-31 0001760903 BNKK:CommonStockPayableMember 2025-01-01 2025-03-31 0001760903 us-gaap:RetainedEarningsMember 2025-01-01 2025-03-31 0001760903 2025-01-01 2025-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-04-01 2025-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-04-01 2025-06-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-04-01 2025-06-30 0001760903 us-gaap:TreasuryStockPreferredMember 2025-04-01 2025-06-30 0001760903 us-gaap:CommonStockMember 2025-04-01 2025-06-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-04-01 2025-06-30 0001760903 BNKK:CommonStockPayableMember 2025-04-01 2025-06-30 0001760903 us-gaap:RetainedEarningsMember 2025-04-01 2025-06-30 0001760903 2025-04-01 2025-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-07-01 2025-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-07-01 2025-09-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-07-01 2025-09-30 0001760903 us-gaap:TreasuryStockPreferredMember 2025-07-01 2025-09-30 0001760903 us-gaap:CommonStockMember 2025-07-01 2025-09-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-07-01 2025-09-30 0001760903 BNKK:CommonStockPayableMember 2025-07-01 2025-09-30 0001760903 us-gaap:RetainedEarningsMember 2025-07-01 2025-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-01-01 2026-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-01-01 2026-03-31 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-01-01 2026-03-31 0001760903 us-gaap:TreasuryStockPreferredMember 2026-01-01 2026-03-31 0001760903 us-gaap:CommonStockMember 2026-01-01 2026-03-31 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-01-01 2026-03-31 0001760903 BNKK:CommonStockPayableMember 2026-01-01 2026-03-31 0001760903 us-gaap:RetainedEarningsMember 2026-01-01 2026-03-31 0001760903 2026-01-01 2026-03-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-04-01 2026-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-04-01 2026-06-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-04-01 2026-06-30 0001760903 us-gaap:TreasuryStockPreferredMember 2026-04-01 2026-06-30 0001760903 us-gaap:CommonStockMember 2026-04-01 2026-06-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-04-01 2026-06-30 0001760903 BNKK:CommonStockPayableMember 2026-04-01 2026-06-30 0001760903 us-gaap:RetainedEarningsMember 2026-04-01 2026-06-30 0001760903 2026-04-01 2026-06-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-07-01 2026-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-07-01 2026-09-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-07-01 2026-09-30 0001760903 us-gaap:TreasuryStockPreferredMember 2026-07-01 2026-09-30 0001760903 us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-07-01 2026-09-30 0001760903 BNKK:CommonStockPayableMember 2026-07-01 2026-09-30 0001760903 us-gaap:RetainedEarningsMember 2026-07-01 2026-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2025-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2025-09-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2025-09-30 0001760903 us-gaap:TreasuryStockPreferredMember 2025-09-30 0001760903 us-gaap:CommonStockMember 2025-09-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001760903 BNKK:CommonStockPayableMember 2025-09-30 0001760903 us-gaap:RetainedEarningsMember 2025-09-30 0001760903 2025-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-09-30 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassBMember 2026-09-30 0001760903 us-gaap:PreferredStockMember BNKK:PreferredClassCMember 2026-09-30 0001760903 us-gaap:TreasuryStockPreferredMember 2026-09-30 0001760903 us-gaap:CommonStockMember 2026-09-30 0001760903 us-gaap:AdditionalPaidInCapitalMember 2026-09-30 0001760903 BNKK:CommonStockPayableMember 2026-09-30 0001760903 us-gaap:RetainedEarningsMember 2026-09-30 0001760903 2025-01-01 2025-12-31 0001760903 srt:SubsidiaryIssuerMember us-gaap:OtherInvesteesMember 2026-09-30 0001760903 srt:SubsidiaryIssuerMember us-gaap:OtherInvesteesMember srt:MinimumMember 2026-09-30 0001760903 srt:SubsidiaryIssuerMember us-gaap:OtherInvesteesMember srt:MaximumMember 2026-09-30 0001760903 BNKK:SingleReportableSegmentMember 2026-01-01 2026-09-30 0001760903 BNKK:ChiefOperatingDecisionMakerMember BNKK:SegmentRevenueAndGrossProfitMember 2026-01-01 2026-09-30 0001760903 BNKK:ChiefOperatingDecisionMakerMember BNKK:SegmentRevenueAndGrossProfitMember 2025-01-01 2025-12-31 0001760903 BNKK:ChiefOperatingDecisionMakerMember 2026-01-01 2026-09-30 0001760903 BNKK:ChiefOperatingDecisionMakerMember 2025-01-01 2025-12-31 0001760903 BNKK:CustomerMember 2026-09-30 0001760903 BNKK:ClientMasterTradingArrangementMember BNKK:STSDigitalLtdMember 2026-09-09 2026-09-09 0001760903 BNKK:ClientMasterTradingArrangementMember BNKK:STSDigitalLtdMember 2026-09-09 0001760903 BNKK:ClientMasterTradingArrangementMember BNKK:STSDigitalLtdMember 2026-09-30 0001760903 BNKK:ClientMasterTradingArrangementMember BNKK:STSDigitalLtdMember 2026-01-01 2026-09-30 0001760903 BNKK:BonkMember 2026-09-30 0001760903 BNKK:USD1Member 2026-09-30 0001760903 BNKK:SOLMember 2026-09-30 0001760903 BNKK:WSOLMember 2026-09-30 0001760903 BNKK:BonkMember 2025-12-31 0001760903 BNKK:USD1Member 2025-12-31 0001760903 BNKK:USDCMember 2025-12-31 0001760903 BNKK:SOLMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:BonkMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:BonkMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:BonkMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:USD1Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:USD1Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:USD1Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:SOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:SOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:SOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:WSOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:WSOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:WSOLMember 2026-09-30 0001760903 us-gaap:FairValueInputsLevel1Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel2Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel3Member 2026-09-30 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:BonkMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:BonkMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:BonkMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:USD1Member 2025-12-31 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:USD1Member 2025-12-31 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:USD1Member 2025-12-31 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:USDCMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:USDCMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:USDCMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel1Member BNKK:SOLMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel2Member BNKK:SOLMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel3Member BNKK:SOLMember 2025-12-31 0001760903 us-gaap:FairValueInputsLevel1Member 2025-12-31 0001760903 us-gaap:FairValueInputsLevel2Member 2025-12-31 0001760903 us-gaap:FairValueInputsLevel3Member 2025-12-31 0001760903 BNKK:YerbaeBrandsCorpMember 2025-06-27 0001760903 BNKK:YerbaeBrandsCorpMember us-gaap:CommonStockMember 2025-06-27 2025-06-27 0001760903 BNKK:YerbaeBrandsCorpMember us-gaap:CommonStockMember 2025-06-27 0001760903 BNKK:YerbaeBrandsCorpMember srt:RestatementAdjustmentMember 2025-12-31 0001760903 BNKK:YerbaeBrandsCorpMember 2025-12-31 0001760903 BNKK:TronIncMember BNKK:StockExchangeAgreementMember 2025-01-01 2025-12-31 0001760903 BNKK:TronIncMember BNKK:StockExchangeAgreementMember 2026-01-01 2026-09-30 0001760903 BNKK:CaringBrandsIncMember BNKK:StockPurchaseAgreementMember 2025-12-31 0001760903 BNKK:CaringBrandsIncMember BNKK:StockPurchaseAgreementMember 2026-01-01 2026-09-30 0001760903 BNKK:CaringBrandsIncMember BNKK:StockPurchaseAgreementMember 2026-09-30 0001760903 BNKK:CaringBrandsIncMember 2026-01-01 2026-09-30 0001760903 BNKK:CaringBrandsIncMember 2025-01-01 2025-12-31 0001760903 BNKK:EliteHealthPartnersMember 2026-01-01 2026-09-30 0001760903 BNKK:EliteHealthPartnersMember 2025-01-01 2025-12-31 0001760903 BNKK:YerbaeTradenameAndTradeSecretsMember 2026-09-30 0001760903 BNKK:YerbaeTradenameAndTradeSecretsMember 2025-12-31 0001760903 BNKK:YerbaeNonCompetesMember 2026-09-30 0001760903 BNKK:YerbaeNonCompetesMember 2025-12-31 0001760903 BNKK:RevenueSharingAgreementMember 2025-08-08 2025-08-08 0001760903 BNKK:RevenueSharingAgreementMember srt:MinimumMember 2025-12-03 2025-12-03 0001760903 BNKK:RevenueSharingAgreementMember srt:MaximumMember 2025-12-03 2025-12-03 0001760903 BNKK:ConvertibleNoteAgreementMember BNKK:BiggerCapitalLLPMember us-gaap:SecuredDebtMember 2025-01-20 0001760903 BNKK:ConvertibleNoteAgreementMember BNKK:BiggerCapitalLLPMember us-gaap:SecuredDebtMember 2025-01-20 2025-01-20 0001760903 BNKK:ConvertibleNoteAgreementMember BNKK:BiggerCapitalLLPMember us-gaap:ConvertibleDebtMember 2025-01-20 0001760903 BNKK:ConvertibleNoteAgreementMember BNKK:BiggerCapitalLLPMember us-gaap:ConvertibleDebtMember 2025-01-20 2025-01-20 0001760903 us-gaap:ConvertibleDebtMember 2025-12-31 0001760903 us-gaap:ConvertibleDebtMember 2025-01-01 2025-12-31 0001760903 us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-12-31 0001760903 us-gaap:SeriesBPreferredStockMember 2025-07-02 2025-07-02 0001760903 BNKK:ConvertiblePromissoryNotesMember 2024-12-31 0001760903 BNKK:ConvertiblePromissoryNotesMember 2025-01-01 2025-12-31 0001760903 BNKK:ConvertiblePromissoryNotesMember 2025-12-31 0001760903 BNKK:EconomicInjuryDisasterLoanProgramMember 2020-01-01 2020-12-31 0001760903 BNKK:EconomicInjuryDisasterLoanProgramMember 2021-01-01 2021-12-31 0001760903 BNKK:EconomicInjuryDisasterLoanProgramMember 2021-12-31 0001760903 BNKK:SeriesAOneConvertiblePreferredStockMember 2025-05-02 0001760903 BNKK:SeriesATwoConvertiblePreferredStockMember 2025-05-02 0001760903 BNKK:SeriesAThreeConvertiblePreferredStockMember 2025-05-02 0001760903 us-gaap:SeriesAPreferredStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:CommonStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:PreferredStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:SeriesAPreferredStockMember 2025-05-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:SeriesAPreferredStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:CommonStockMember 2025-05-02 0001760903 BNKK:ExchangeAgreementMember BNKK:SeriesA1ConvertiblePreferredStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember BNKK:SeriesA2ConvertiblePreferredStockMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember 2025-05-02 0001760903 BNKK:ExchangeAgreementMember 2025-05-02 2025-05-02 0001760903 BNKK:ExchangeAgreementMember srt:MinimumMember 2025-05-02 0001760903 BNKK:ExchangeAgreementMember srt:MaximumMember 2025-05-02 0001760903 BNKK:ExchangeAgreementMember 2025-05-02 2026-05-02 0001760903 BNKK:PreferredStockRedemptionAgreementMember us-gaap:SeriesAPreferredStockMember 2026-09-30 0001760903 BNKK:PreferredStockRedemptionAgreementMember us-gaap:PreferredStockMember BNKK:Core4CapitalCorpMember 2026-01-01 2026-09-30 0001760903 us-gaap:PreferredStockMember 2026-09-04 2026-09-04 0001760903 us-gaap:CommonStockMember 2026-09-04 2026-09-04 0001760903 us-gaap:SeriesAPreferredStockMember 2026-09-30 0001760903 us-gaap:SeriesAPreferredStockMember 2025-12-31 0001760903 us-gaap:SeriesBPreferredStockMember 2025-07-02 0001760903 BNKK:ExchangeAgreementMember us-gaap:SeriesBPreferredStockMember 2025-01-01 2025-12-31 0001760903 BNKK:ExchangeAgreementMember us-gaap:CommonStockMember 2025-01-01 2025-12-31 0001760903 BNKK:ExchangeAgreementMember us-gaap:SeriesBPreferredStockMember 2026-04-01 2026-04-30 0001760903 BNKK:ExchangeAgreementMember us-gaap:CommonStockMember 2026-07-01 2026-09-30 0001760903 us-gaap:SeriesBPreferredStockMember 2026-09-30 0001760903 us-gaap:SeriesBPreferredStockMember 2025-12-31 0001760903 BNKK:AugustPurchaseAgreementMember us-gaap:SeriesCPreferredStockMember 2025-08-08 0001760903 BNKK:AugustPurchaseAgreementMember us-gaap:CommonStockMember 2025-08-08 2025-08-08 0001760903 BNKK:AugustPurchaseAgreementMember us-gaap:CommonStockMember 2025-08-08 0001760903 us-gaap:InvestorMember 2025-08-08 2025-08-08 0001760903 BNKK:RevenueSharingAgreementMember us-gaap:SeriesCPreferredStockMember 2025-08-08 0001760903 BNKK:RevenueSharingAgreementMember us-gaap:CommonStockMember 2025-08-08 2025-08-08 0001760903 BNKK:RevenueSharingAgreementMember us-gaap:CommonStockMember 2025-08-08 0001760903 BNKK:RevenueSharingAgreementMember 2025-12-31 0001760903 BNKK:RevenueSharingAgreementMember 2025-01-01 2025-12-31 0001760903 us-gaap:SeriesCPreferredStockMember 2025-08-08 2025-08-08 0001760903 us-gaap:SeriesCPreferredStockMember 2025-08-11 0001760903 2025-08-11 0001760903 us-gaap:SeriesCPreferredStockMember 2025-08-11 2025-08-11 0001760903 2025-08-11 2025-08-11 0001760903 BNKK:CommonStockPayablesMember 2025-12-31 0001760903 BNKK:CommonStockPayablesMember 2026-01-01 2026-09-30 0001760903 BNKK:CommonStockPayablesMember 2026-09-30 0001760903 us-gaap:WarrantMember 2024-01-01 2024-12-31 0001760903 us-gaap:WarrantMember 2024-12-31 0001760903 BNKK:ExchangeWarrantMember 2024-01-01 2024-12-31 0001760903 BNKK:ExchangeWarrantMember 2024-12-31 0001760903 2024-01-01 2024-12-31 0001760903 us-gaap:PreferredStockMember us-gaap:PreferredClassAMember 2026-01-01 2026-09-30 0001760903 us-gaap:WarrantMember us-gaap:SeriesAPreferredStockMember 2026-01-01 2026-09-30 0001760903 us-gaap:WarrantMember 2026-01-01 2026-09-30 0001760903 us-gaap:WarrantMember BNKK:ScenarioOneMember srt:MinimumMember 2026-09-30 0001760903 us-gaap:WarrantMember BNKK:ScenarioOneMember srt:MaximumMember 2026-09-30 0001760903 BNKK:StockOptionsToEmployeesMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember srt:MinimumMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember srt:MaximumMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember BNKK:VestedImmediatelyUponGrantMember 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember BNKK:VestedImmediatelyUponGrantMember srt:MinimumMember 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember BNKK:VestedImmediatelyUponGrantMember srt:MaximumMember 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember BNKK:VestThroughTwoThousandTwentySixMember 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember BNKK:VestThroughTwoThousandTwentySixMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember srt:MinimumMember 2025-01-01 2025-12-31 0001760903 BNKK:StockOptionsToEmployeesMember us-gaap:ShareBasedCompensationAwardTrancheOneMember srt:MaximumMember 2025-01-01 2025-12-31 0001760903 us-gaap:EmployeeStockOptionMember 2026-01-01 2026-09-30 0001760903 us-gaap:EmployeeStockOptionMember 2026-09-30 0001760903 us-gaap:EmployeeStockOptionMember 2025-12-31 0001760903 2026-05-06 2026-05-06 0001760903 2024-02-09 0001760903 2024-02-09 2024-02-09 0001760903 2026-02-04 2026-02-04 0001760903 2026-02-04 0001760903 2026-07-29 0001760903 us-gaap:SubsequentEventMember 2026-10-16 0001760903 2025-12-15 2025-12-15 0001760903 2025-09-03 2025-09-03 0001760903 2025-07-29 2025-07-29 0001760903 2025-07-31 2025-07-31 0001760903 us-gaap:EmployeeStockOptionMember srt:MinimumMember 2025-01-01 2025-12-31 0001760903 us-gaap:EmployeeStockOptionMember srt:MaximumMember 2025-01-01 2025-12-31 0001760903 us-gaap:EmployeeStockOptionMember 2025-01-01 2025-12-31 0001760903 us-gaap:SubsequentEventMember 2026-10-01 2026-11-13 iso4217:USD xbrli:shares iso4217:USD xbrli:shares BNKK:Segments xbrli:pure BNKK:Token

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

Form 10-Q

 

(Mark One)

 

☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2026

 

or

 

☐ TRANSITION REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from _______________ to _____________

 

Commission File Number 001-39569

 

BONK, INC.

(Exact name of registrant as specified in charter)

 

Delaware   83-2455880
(State or other jurisdiction of   (IRS Employer
incorporation or organization)   Identification No.)
     

60 E Rio Salado Pkwy, Suite 900

Tempe, AZ

  85281
(Address of principal executive offices)   (Zip Code)

 

(888) 257-8061

 

(Registrant’s telephone number, including area code)

 

Not Applicable

 

(Former name, former address and former fiscal year, if changed since last report)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol   Name of exchange on which registered
Common Stock, $.001 par value per share   BNKK   Nasdaq
Warrants to purchase shares of common stock   BNKKW   Nasdaq

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. ☒ YES ☐ NO

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be pursuant to Rule 405 of Regulation S- T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). ☒ YES ☐ NO

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ☐ Accelerated filer ☐
Non-accelerated filer ☒ Smaller reporting company ☒
    Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act) ☐ YES ☒ NO

 

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

 

As of November 16, 2026 there were 8,583,083 shares of the registrant’s common stock outstanding.

 

 

 

 
 

 

FORM 10-Q

TABLE OF CONTENTS

 

PART I - FINANCIAL INFORMATION
   
Item 1. Financial Statements F-1
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 2
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 8
     
Item 4. Controls and Procedures 8
     
PART II - OTHER INFORMATION  
     
Item 1. Legal Proceedings 9
     
Item 1A. Risk Factors 9
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 9
     
Item 3. Defaults Upon Senior Securities 9
     
Item 4. Mine Safety Disclosures 9
     
Item 5. Other Information 9
     
Item 6. Exhibits 10
     
SIGNATURES 11

 

i
Table of Contents

 

PART I - FINANCIAL INFORMATION

 

This Quarterly Report on Form 10-Q includes the accounts of Bonk, Inc., a Delaware corporation (“Bonk”). References in this Report to “we”, “our”, “us” or the “Company” refer to Bonk, Inc. and its consolidated subsidiaries unless the context dictates otherwise.

 

FORWARD LOOKING STATEMENTS

 

Certain statements in this report, including information incorporated by reference, are “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements reflect current views about future events and financial performance based on certain assumptions. They include opinions, forecasts, intentions, plans, goals, projections, guidance, expectations, beliefs or other statements that are not statements of historical fact. Words such as “will,” “may,” “should,” “could,” “would,” “expects,” “plans,” “believes,” “anticipates,” “intends,” “estimates,” “approximates,” “predicts,” “forecasts,” “potential,” “continue,” or “projects,” or the negative or other variation of such words, and similar expressions may identify a statement as a forward-looking statement. Any statements that refer to projections of our future financial performance, our anticipated growth and trends in our businesses, our goals, strategies, focus and plans, and other characterizations of future events or circumstances, including statements expressing general optimism about future operating results and the development of our products, are forward-looking statements.

 

Although forward-looking statements in this Quarterly Report on Form 10-Q reflect the good faith judgment of our management, such statements can only be based on facts and factors currently known by us. Consequently, forward-looking statements are inherently subject to risks and uncertainties and actual results and outcomes may differ materially from the results and outcomes discussed in or anticipated by the forward-looking statements. Factors that could cause or contribute to such differences in results and outcomes include, without limitation, those specifically addressed under the heading “Risk Factors” below, as well as those discussed elsewhere in this Quarterly Report on Form 10-Q. Readers are urged not to place undue reliance on these forward-looking statements, which speak only as of the date of this Quarterly Report on Form 10-Q. We file reports with the Securities and Exchange Commission (“SEC”). The public can read and copy any materials we file with the SEC at the SEC’s Public Reference Room at 100 F Street, NE, Washington, DC 20549. You can obtain additional information about the operation of the Public Reference Room by calling the SEC at 1-800-SEC-0330. In addition, the SEC maintains an Internet site (www.sec.gov) that contains reports, proxy and information statements, and other information regarding issuers that file electronically with the SEC, including us.

 

We undertake no obligation to revise or update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this Quarterly Report on Form 10-Q. Readers are urged to carefully review and consider the various disclosures made throughout the entirety of this Quarterly Report on Form 10-Q, which attempt to advise interested parties of the risks and factors that may affect our businesses, financial condition, results of operations and prospects.

 

1
Table of Contents

  

Item 1. Financial Statements

 

Bonk, Inc.

 

  Page
   
Consolidated Balance Sheets as of September 30, 2026 (Unaudited) and December 31, 2025 (Audited) F-2
Consolidated Statements of Operations for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) F-3
Consolidated Statements of Shareholders’ Equity for the Three and Nine Months Ended September 30, 2026 and 2025 (Unaudited) F-4
Consolidated Statements of Cash Flows for the Nine-Months Ended September 30, 2026 and 2025 (Unaudited) F-5
Notes to the Consolidated Financial Statements (Unaudited) F-6

 

F-1
Table of Contents

 

Bonk, Inc.

Consolidated Balance Sheets

As of September 30, 2026 and December 31, 2025

 

   As of   As of 
   30-Sep-26   31-Dec-25 
   (Unaudited)   (Audited) 
Assets          
Current assets:          
Cash  $90,507   $2,278,340 
Marketable Securities   -    54,720 
Digital Assets   3,368,230    630,605 
Inventory   284,018    949,275 
Account receivable   63,632    90,140 
Prepaid expenses and deposits   900,134    1,839,484 
Investment in Affiliate   67,421    1,600 
Equity Securities   -    58,456 
Note Receivable   6,064,379    - 
Loan to affiliates   139,405    139,405 
Total current assets   10,977,726    6,042,025 
Non-current assets:          
Non-current digital assets   -    17,344,636 
Right of use assets   -    18,570 
Goodwill   14,147,778    14,147,778 
Related party revenue sharing - other asset, net of amortization   1,657,735    2,060,968 
Intangible assets, net of amortization   1,190,386    1,293,247 
Fixed assets, net of depreciation   34,066    66,191 
Total non-current assets   17,029,965    34,931,390 
Total Assets  $28,007,691    40,973,415
           
Liabilities and Shareholders’ Equity          
Accounts Payable  $1,832,956   $2,476,773 
Accounts Payable to Affiliate   132,193    - 
Accrued expenses   1,693,326    3,152,544 
Note payable, current portion   323,877    275,000 
Current portion of lease liability   -    23,544 
STS Digital Loan   3,000,000    - 
Covid - 19 SBA Loan   50,476    49,210 
Total current Liabilities   7,032,828    5,977,071 
           
Total liabilities  $7,032,828    5,977,071 
           
Preferred stock, $0.001 par value, 1,000,000 shares authorized of which 26,667 shares are held in Treasury   27    - 
Preferred stock, $0.001 par value, 1,000,000 shares authorized of which 208,000 and 176,806 shares issued and outstanding as of September 30, 2026 and December 31, 2025 respectively   208    177 
Common stock, $.001 par value, 1,000,000,000 shares authorized, of which 7,943,083 and 7,751,707 shares issued and outstanding as of September 30, 2026 and December 31, 2025   7,943    7,751 
Additional paid-in capital   214,494,204    215,979,259 
Common stock payable   409,200    2,501,336 
Accumulated deficits   (193,936,719)   (183,492,179)
Total Shareholders’ Equity   20,974,863    34,996,344 
           
Total Liabilities and Shareholders’ Equity  $28,007,691   $40,973,415 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

F-2
Table of Contents

 

Bonk, Inc.

Consolidated Statement of Operations

For the Three and Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

   2026   2025   2026   2025 
   Three Months Ended September 30,   Nine Months Ended September 30, 
   2026   2025   2026   2025 
Revenue                
Sales  $692,280   $1,514,817   $2,271,548   $1,601,865 
Related party revenue share   186,499    509,085    4,107,694    509,085 
Cost of Sales   877,166    1,480,760    2,393,534    1,522,942 
Gross profit   1,613    543,142    3,985,708    588,008 
                     
Operating expense                    
General and administrative expenses   1,626,519    17,215,566    6,271,700    26,990,405 
Total operating expenses   1,626,519    17,215,566    6,271,700    26,990,405 
Other income / (expense)                    
Interest income   466    72,227    9,689    64,863 
Interest expense   -    (273,711)   (40,254)   (496,840)
Impairment of promissory note   (50,000)   -    (50,000)   - 
Taxes   -    -    (47,248)   - 
Gain on sale of marketable securities   -    -    -    180,556 
Loss on deconsolidation   -    -    (53,034)   - 
Realized gain on sale of stock   -    500,000    796,404    500,000 
Gain (Loss) on Settlement   (41,114)   (4,278,036)   377,978    (4,640,465)
Gain (Loss) on exchange   -    (120,446)   -    (120,446)
Realized gain (loss) on exchange of digital assets   (7,345,237)   -    (7,515,268)   - 
Unrealized gain on receivable   1,262,843    -    1,262,843    - 
Unrealized gain(loss) on equity investment   (207,982)   (5,595,353)   (190,539)   12,594,998 
Unrealized gain/(loss) on digital asset   5,388,025   (7,213,473)   (2,779,399)   (7,213,473)
Other income / (expense)   56,680    -    70,280    - 
Total other income (expense)   (936,319)   (16,908,792)   (8,158,548)   869,193 
                     
Net Loss  $(2,561,225)  $(33,581,216)  $(10,444,540)  $(25,533,204)
Less: deemed dividend on Series A Preferred stock exchange  $(1,114,378)  $-   $(1,114,378)  $- 
Net loss attributable to common stockholders  $(3,675,603)  $(33,581,216)  $(11,558,918)  $(25,533,204)
Net (loss) per share:                    
Loss per share attributed to common shareholders basic and diluted   (0.46)  $(7.82)  $(1.45)  (8.83)
Weighted average number of shares                  
Basic   8,044,402    4,293,869    7,977,166    2,891,519 
Diluted   8,044,402    -    7,977,166    - 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

F-3
Table of Contents

 

Bonk, Inc.

Consolidated Statement of Shareholders’ Equity

For the Three and Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

  

Number

of

Shares

   Par Value  

Number

of

Shares

   Par Value  

Number

of

Shares

  

Par

Value

             

Number

of

Shares 

   Par Value  

Additional

Paid in

Capital

  

Common

Stock

Payable

  

Accumulated

Deficits

   Total 
  

Number

of

Shares

   Par Value  

Number

of

Shares

   Par Value  

Number

of

Shares

  

Par

Value

    Number of Shares     Par Value  

Number

of

Shares 

   Par Value  

Additional

Paid in

Capital

  

Common

Stock

Payable

  

Accumulated

Deficits

   Total 
Balance, December 31, 2024   -   $-    -   $-    -   $-       -        -     1,789,724   $1,789    110,917,570   $1,997,936    (115,090,347)   (2,173,052)
         -    -    -    -    -       -       -                             - 
Common Stock issued for serviced   -    -    -    -    -    -       -       -    44,857    45    1,715,455    (756,250)   -    959,250 
Common Stock due for bonus   -    -    -    -    -    -       -       -    -    -    -    347,500    -    347,500 
Common Stock issued for litigation settlement   -    -    -    -    -    -       -       -    55,075    55    809,553    (809,608)        0 
Common Stock issued for private placement   -    -    -    -    -    -       -       -    258,247    258    3,806,515    1,165,198         4,971,971 
Fair value of options granted   -    -    -    -    -    -       -       -    -    -    678,626    -    -    678,626 
Net loss for the three months ended March 31, 2025   -    -    -    -    -    -       -       -    -    -    -    -    (5,326,933)   (5,326,933)
Balance, March 31, 2025   -   $-    -   $-    -   $-       -     $ -     2,147,903   $2,147   $117,927,719   $1,944,776   $(120,417,280)  $(542,638)
Common stock issued in connection with Yerbae acquisition   -    -    -    -    -    -       -       -    568,056    568    5,983,898    -    (216,070)   5,768,396 
Common stock issued for cash   -    -    -    -    -    -       -       -    88,395    88    1,220,711    -         1,220,799 

Common stock issued in exchange for settlement of payables
   -    -    -    -    -    -       -       -    197,143    197    1,216,605    244,998         1,461,800 
Common stock issued for settlement   -    -    -    -    -    -       -       -    32,667    33    399,968    -         400,001 
Common stock issued for employee bonus   -    -    -    -    -    -       -       -    7,143    7    65,383    (65,390)        0 
Common stock issued for services   -    -    -    -    -    -       -       -    53,007    53    1,166,305    (347,500)        818,858 
Conversion of Common stock to Preferred stock   39,933    40    -    -    -    -       -       -    (187,858)   (188)   (335,227)   335,375         0 
Warrant purchase agreement   -    -    -    -    -    -       -       -    -    -    500,000    -         500,000 
Stock compensation expense   -    -    -    -    -    -       -       -    -    -    86,206    -         86,206 
Net loss   -    -    -    -    -    -       -       -    -    -    -    -    13,374,947    13,374,947 
Balance, June 30, 2025   39,933   $40    -   $-    -   $-       -     $ -    2,906,455   $2,906   $128,231,568   $2,112,259   $(107,258,403)  $23,088,370 
Common stock issued for cash   -    -    -    -    -    -       -       -    1,016,012    1,016    20,186,339    (1,040,998)        19,146,357 
Common stock issued in exchange for settlement of payables   -    -    -    -    -    -       -       -    467,143    467    3,026,015    -    -    3,026,482 
Common stock issued for settlement   -    -    -    -    -    -       -       -    36,071    36    750,242    (81,680)        668,598 
Common stock due for services   -    -    -    -    -    -       -       -    -    -    -    264,375         264,375 
Common stock issued for services   -    -    -    -    -    -       -       -    17,857    18    264,357    (264,375)        (0)
Loss on Preferred A stock a issued for common stock exchange   -    -    -    -    -    -       -       -    -    -    120,446    -         120,446 
Preferred stock B issued for convertible note   -    -    7,212    7    -    -       -       -    -    -    5,408,518              5,408,525 
Preferred stock C issued for Digital Asset Agreement   -    -    -    -    135,000    135       -       -    -    -    27,284,852              27,284,987 
Warrant purchase agreement   -    -    -    -    -    -       -       -    5,714    6    49,994    -    -    50,000 
Stock compensation expense   -    -    -    -    -    -       -       -    449,082    449    7,672,361    367,500         8,040,310 
Fair value of options granted   -    -    -    -    -    -       -       -    -    -    466,917    -    -    466,917 
Common stock to be issued for digital asset agreement   -    -    -    -    -    -            -                -    -    -    -    21,535,069         21,535,069 
Net loss   -    -    -    -    -    -       -       -                        (33,581,216)   (33,581,216)
Balance, September 30, 2025   39,933   $40    7,212   $7    135,000   $135       -        -     4,898,335   $4,898   $193,461,609   $22,892,150   $(140,839,619)  $75,519,220 

 

  

Number

of

Shares

   Par Value  

Number

of

Shares

  

Par

Value

  

Number of

Shares

 

 

 

Par

Value

                 

Number

of

Shares

  

Par

Value

  

Additional

Paid in

Capital

  

Common

Stock

Payable

  

Accumulated

Deficits

   Total 
  

Preferred A

Stock

  

Preferred B

Stock

  

Preferred C

Stock

    Treasury Stock   Common Stock                 
  

Number

of

Shares

   Par Value  

Number

of

Shares

  

Par

Value

  

Number of

Shares

 

 

 

Par

Value

    Number of Shares     Par Value  

Number

of

Shares

  

Par

Value

  

Additional

Paid in

Capital

  

Common

Stock

Payable

  

Accumulated

Deficits

   Total 
Balance, December 31, 2025   39,933   $40  1,813   $2   135,000 $  135       -       -   7,751,707   $7,751   $215,979,259   $2,501,336   $(183,492,179)  $34,996,344 
Common stock issued for stock payable        -    -    -    -    -       -       -    117,943    118    1,532,418    (1,532,536)   -    - 
Fair value of options granted   -    -    -    -    -    -       -       -    -    -    115,801    -    -    115,801 
Net loss for the three months ended March 31, 2025   -    -    -    -    -    -       -       -    -    -    -    -    (1,828,643)   (1,828,643)
Balance, March 31, 2026   39,933   $40   1,813   $2   135,000   $135       -       -   7,869,650   $7,869    217,627,478   $968,800   $(185,320,822)   33,283,502 
Stock compensation expense   -    -    -    -    -    -       -       -    17,857    18    264,357    16,800    -    281,175 
Fair value of options granted   -    -    -    -    -    -       -       -    -    -    14,172    -    -    14,172 
Preferred stock converted to common   -    -    (1,813)   (2)   -    -       -       -    114,625    115    (113)   -    -    - 
Pre-split common stock adjustment   -    -    -    -    -    -       -       -    (1,192)   (1)   -    -    1    (0)
Net Income (loss)   -    -         -    -    -       -       -    -    -    -    -    (6,054,673)   (6,054,673)
Balance June 30, 2026   39,933   $40   -   $-   135,000   $135       -       -   8,000,940   $8,001    217,905,894   $985,600   $(191,375,494)   27,524,176 
Stock compensation expense   -    -    -    -    -    -       -       -    -    -    -    -    -    - 
Fair value of options granted   -    -    -    -    -    -       -       -    -    -    11,912    -    -    11,912 
Common stock issued for services   -    -    -    -    -    -       -       -    17,142    17    131,383    (131,400)   -    - 
Common stock issued for bonuses   -    -    -    -    -    -       -       -    28,572    29    444,971    (445,000)   -    - 
Conversion of common stock into preferred   22,016    22    -    -    -    -       -       -    (103,571)   (104)   82    -    -    0 
Warrants exchanged for preferred A stock   38,051    38    -    -    -    -       -       -    -    -    (38)             0 
Core4 preferred exchange and redemption agreement   (26,667)   (27)   -    -    -    -       -       -    -    -    (4,000,000)   -    -    (4,000,027)
Treasury stock due to Core4 redemption agreement   -    -    -    -    -    -       26,667       27    -    -    -   -    -    27 
FV of common stk/warants exchanged for issuance of Preferred A stock   -    -    -    -    -    -       -       -    -    -    1,114,378    -    -    1,114,378 
Deemed dividend   -    -    -    -    -    -       -       -    -    -    (1,114,378)   -    -    (1,114,378)
Net Income (loss)   -    -    -    -    -    -               -    -    -    -    -    (2,561,225)   (2,561,225)
Balance September 30, 2026   73,333   $73   -   $-   135,000   135       26,667       27   7,943,083   $7,943    214,494,204   $409,200   $(193,936,719)   20,974,863 

 

The accompanying notes are an integral part of these financial statements.

 

F-4
Table of Contents

 

Bonk, Inc.

Consolidated Statement of Cash Flows

For the Nine Months Ended September 30, 2026 and 2025

(Unaudited)

 

   2026   2025 
   Nine Months Ended September 30, 
   2026   2025 
Cash flows from operating activities:          
Net income (loss)  $(10,444,540)  $(25,533,204)
Stock Based compensation   281,175    - 
Depreciation & Amortization   538,219    423,822 
Fair value of shares issued for services rendered   -    9,818,419 
Fair value of common stock due for services   -    264,375 
Fair value of options granted   141,885    - 
Fair value of shares issued for employe bonus   -    347,500 
Fair value of options issued for services   -    1,231,750 
Fair value of common stock issued for settlement   -    918,598 
Fair value of SRM shares granted in connection with settlement   -    391,000 
Realized gain on sale of stock   (197,904)   - 
Loss on exchange   -    120,446 
Realized loss on exchange of digital assets   7,515,268    - 
Unrealized gain on note receivable   (1,262,843)   - 
(Gain)/Loss on Settlements   (422,978)   - 
Unrealized (gain) loss on equity investment   190,539    (12,594,998)
Unrealized (gain) loss on digital assets   2,779,399    7,213,473 
Related party revenue share paid in Crypto   (4,107,694)   (509,085)
Loss on Deconsolidation   54,720    - 
Adjustments to reconcile net income to net cash provided by (used in) operating activities        
Prepaid expenses and deposits   939,350    (1,614,104)
Right of Use asset   18,570    328,821 
Accounts receivable   37,049    94,856 
Note receivable   -    126,512 
Inventory   665,257    (127,025)
Accounts payable   (511,624)   2,105,493 
Accrued liabilities   (1,034,975)   (781,133)
Lease liability   (23,544)   (361,007)
Net cash (used in) operating activities   (4,844,671)   (18,135,491)
           
Cash flows from investing activities:          
Acquisition of Yerbae   -    (109,710)
Investment in Yerbae   -    (925,000)
Cash received from sale of investments   -    12,105,000 
Proceeds from STS Digital Loan   3,000,000    - 
Fair value of digital assets sold for cash   3,607,961    - 
Purchase of intangible assets   -    (704,189)
Purchase of digital assets   -    (5,000,037)
Purchase of equipment   -    60 
Net cash provided by (used in) investing activities   6,607,961    5,366,124 
           
Cash flows from financing activities:          
Shares issued for private placement   -    4,971,970 
Loan payable on insurance   173,877    - 
Fair value of Treasury stock due to Core4 Agreement   (4,000,000)   - 
Repayments of convertible notes   -    (4,508,315)
Proceeds of issuance of common stock   -    20,367,156 
Proceeds from warrant purchase agreement   -    550,000 
Repayments of note payable   (125,000)   - 
Net cash provided by (used in) financing activities   (3,951,123)   21,380,811 
           
Net increase (decrease) in cash and cash equivalents  $(2,187,833)  $ 8,611,444 
           
Cash and cash equivalents at the beginning of the period  $2,278,340   $348,816 
           
Cash and cash equivalents at the end of the period  $90,507   $8,960,260
           
SUPPLEMENTAL CASH FLOW INFORMATION:          
Common stock issued from stock payable on service   1,663,936    - 
Preferred B stock converted to common   115    - 
Investment in GBB asset   -    - 
Common stock issued for Bonk Coins   -    21,535,069 
Shares issued for L & H   -    81,680 
Fair value of common stock issued in exchange for settlement of payables   -    4,488,282 
Fair value of digital asset used to secure loan   4,801,536    - 
Issuance of Preferred Stock B in connection with payoff of Convertible notes   -    5,408,525 
Issuance of Preferred Stock C in connection in exchange for digital assets   -    25,000,000 
Issuance of Preferred Stock C in connection in exchange for digital assets   -    2,284,987 
Common stock issued for services   -    756,250 
Common stock issued for loss on settlement   -    875,000 
FV of common stk/warrants exchanged for issuance of Preferred A stock   104    - 
Deemed Dividend   1,114,378    - 

 

The accompanying notes are an integral part of these unaudited financial statements.

 

F-5
Table of Contents

 

BONK, INC.

Notes to Financial Statements

For the Nine Months Ended September 30, 2026 and Year Ended December 31, 2025

 

Note 1 - Organization and Business Operations

 

Bonk, Inc. (NASDAQ: BNKK) was formerly known as Safety Shot, Inc., and prior to that, Jupiter Wellness, Inc. In August 2023, the Company acquired certain assets of GBB Drink Lab Inc which included the blood alcohol reduction drink Sure Shot (the “Sure Shot Dietary Supplement”), an over-the-counter drink that can lower blood alcohol content to allow recovery from the effects of alcohol by supporting its metabolism. Concurrently with the purchase, the Company changed its name to Safety Shot, Inc. and changed its NASDAQ trading symbol to SHOT. The Company launched the Sure Shot Dietary Supplement in December 2023.

 

On January 8, 2025, the Company entered into an Arrangement Agreement on January 7, 2025 (the “Arrangement Agreement”) with Yerbaé Brands Corp. (“Yerbaé”), pursuant to which the Company agreed, among other things, to acquire all of the issued and outstanding common shares of Yerbaé (the “Yerbaé Shares”) in exchange for shares of common stock of Safety Shot (each, a “Safety Shot Share”) pursuant to a plan of arrangement (the “Plan of Arrangement”) under the Business Corporations Act (British Columbia) (the “Arrangement”). The Arrangement was consummated on June 27, 2025. Yerbaé’s principal subsidiaries are Yerbaé Brands Co. (“Yerbaé USA”) and Yerbaé LLC of which Yerbaé owns 100% interests in, together, “Yerbaé”.

 

On October 10, 2025, the Company changed its corporate name from Safety Shot, Inc. to Bonk, Inc., following the filing of a Certificate of Amendment with the State of Delaware on October 8, 2025. The name change, which became effective on the Nasdaq Capital Market under the new trading symbols “BNKK” and “BNKKW”, reflects the Company’s strategic repositioning and alignment with the BONK ecosystem and its broader focus on digital asset and decentralized finance initiatives.

 

Historically, the Company generated revenue through the sale of its Sure Shot dietary supplement and Yerbaé’s plant-based energy beverage products, which were distributed online and through various retail channels. During 2025, the Company implemented a digital asset strategy in addition to the Company’s beverage sales operations. The Company’s current activities are centered on developing, investing in, and participating in projects aligned with the BONK ecosystem and other blockchain-based initiatives and beverage sales.

 

Going Concern Consideration

 

As of September 30, 2026, and December 31, 2025, the Company had accumulated deficits of $193,936,719 and $183,492,179, respectively, and cash flow used in operations of $4,844,671 and $25,275,375 for the nine months ended September 30, 2026, and year ended December 31, 2025. The Company has incurred and expects to continue to incur significant costs in pursuit of its expansion and development plans. At September 30, 2026 and December 31, 2025, the Company had $90,507 and $2,278,340 respectively, in cash and working capital of $3,944,898 and $64,954, respectively. These conditions have raised substantial doubt about the Company’s ability to continue as a going concern as noted by our auditors, M&K CPAS, PLLC.

 

Note 2 - Significant Accounting Policies

 

Basis of Presentation

 

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Jupiter Wellness Investments, Inc, Yerbaé, and Bonk Holdings, LLC. All intercompany accounts and transactions have been eliminated.

 

F-6
Table of Contents

 

Business Combinations

 

The Company accounts for business combinations in accordance with ASC 805, Business Combinations. The purchase price of an acquired business is allocated to the assets acquired and liabilities assumed based on their estimated fair values as of the acquisition date. The excess of the purchase price over the estimated fair value of the net assets acquired is recorded as goodwill. Identifiable intangible assets are recognized separately from goodwill and are amortized over their estimated useful lives. The determination of fair values requires management to make significant estimates and assumptions. These estimates are inherently uncertain and may be refined for up to one year from the acquisition date as additional information becomes available. Transaction costs incurred in connection with business combinations are expensed as incurred.

 

Use of Estimates

 

The preparation of financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Actual results could differ from those estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with a maturity of three months or less when purchased to be cash and equivalents for purposes of the statement of cash flows. There were no cash equivalents as of September 30, 2026 and December 31, 2025.

 

Deconsolidation

 

The Company will use Deconsolidation Accounting upon the loss of control of a subsidiary determined to be less than 50% owned. Upon deconsolidation, the Company will no longer present the subsidiary’s assets, liabilities, and results of operations in its consolidated financial statements. If the Company owns more than 20% but less than 50% the Company will continue to report under the Equity Method.

 

Discontinued Operations

 

The Company recognized a loss from discontinued operations related to Jupiter Wellness Investments of $53,034 and $0 for the nine months ended September 30, 2026 and nine months ended September 30, 2025, respectively.

 

Trading Securities

 

Securities that the Company intends to sell are classified as trading securities. Trading securities are carried at fair value with gains and losses recognized in current period earnings.

 

Debt Extinguishment and Modification

 

Any changes or modification to debt instruments must be examined to determine if the modification has any significant effect. If the changes or modifications are material, the change or modification must be accounted for as an extinguishment. If determined to be an extinguishment, the change or modification to the original debt is derecognized and a new debt is recognized. Any difference in the fair value is recognized as a gain or loss on extinguishment.

 

F-7
Table of Contents

 

Equity Method for Investments

 

Investments in unconsolidated affiliates, which the Company exerts significant influence but does not control or otherwise consolidate, are accounted for using the equity method. Equity method investments are initially recorded at cost. These investments are included in investment in joint ventures in the accompanying consolidated balance sheets. The Company’s share of the profits and losses from these investments is reported in loss from equity method joint venture in the accompanying consolidated statements of operations. The Company monitors its investments for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the investees and records reductions in carrying values when necessary.

 

Inventory

 

Inventories are stated at the lower of cost or market. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold. Inventory is based upon the average cost method of accounting. During the nine months ended September 30, 2026, the Company took write downs of raw materials due to product expiration totaling $226,802. During the twelve months ended December 31, 2025, the Company had no write-downs or write-offs.

 

Digital Assets

 

Our Digital Assets consist of BONK tokens (“Bonk”), as part of its treasury strategy, that meet the scope requirements of ASC 350-60. The Company accounts for these assets at fair value in accordance with ASC 350-60 and ASC 820, with changes in fair value recognized in net income.

 

Digital Assets are classified as current or noncurrent in the consolidated balance sheet under ASC-210, based on the Company’s intended holding period and liquidity considerations. Assets expected to be sold or used within one year from the reporting date are classified as current assets. Treasury assets not intended to be sold or converted to cash within the operating cycle are classified as noncurrent assets.

 

Crypto assets are not offset against any related liabilities and are presented on a gross basis in the balance sheet, consistent with ASC 210-20.

 

The Company determines the fair value of crypto assets using quoted prices from active markets at the balance sheet date (Level 1 inputs under ASC 820).

 

Gains and losses resulting from changes in fair value are included in the statement of operations.

 

The Company discloses the composition of crypto assets, including fair value by major type of token, as well as the location on the balance sheet and significant changes during the reporting period, in accordance with the disclosure requirements of ASC 350-60.

 

Future sales or exchanges of coins will be accounted for on a first in first out basis (FIFO).

 

90% of revenue that is used to purchase BONK tokens is not legally or contractually restricted. Under the Revenue Sharing Agreement, 90% of gross revenues must be converted into BONK and deposited into the Treasuries Wallet. The agreement does not impose any lock-ups, use-restrictions, release conditions, or prohibitions on sale or transfer after the BONK is received. The BONK tokens are fully available for the Company’s use, without restriction. The Company has full control and the ability to sell, transfer, or use the tokens at any time. The Company has chosen, as part of its long-term economic strategy, not to sell these tokens. This is a voluntary internal policy, not an externally imposed restriction. The Company’s strategic objective is to accumulate BONK in treasury in order to support long-term token stability and ecosystem value, which is consistent with the economic purpose of the revenue-sharing arrangement. Because the tokens are fully under the Company’s control and are not subject to contractual release conditions, they are not “restricted assets”. The Company can access the economic benefits at any time if needed.

 

F-8
Table of Contents

 

Net Loss per Common Share

 

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments such as options, warrants, convertible securities and preferred stock, unless the effect is to reduce a loss or increase earnings per share. As such, options, warrants, convertible securities, and preferred stock are not considered in the calculations, as the impact of the potential common shares would be to decrease the loss per share.

 

Fair Value Measurements

 

The Company follows ASC 820, Fair Value Measurement, which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. Fair value is determined based on the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company classifies assets and liabilities measured at fair value into a three-tier hierarchy based on the observability of inputs used in the valuation:

 

● Level 1 – Quoted prices in active markets for identical assets or liabilities.
● Level 2 – Observable inputs other than Level 1 prices, such as quoted prices for similar assets or liabilities or model-derived valuations in which all significant inputs are observable.
● Level 3 – Unobservable inputs that reflect the Company’s own assumptions about the assumptions that market participants would use.

 

The Company holds certain marketable securities that are measured at fair value on a recurring basis. Convertible debt instruments are initially recorded at fair value, which may include bifurcation of embedded conversion features, if applicable, under ASC 815.

 

Revenue Recognition

 

Beverage Products

 

The Company generates its revenue from the sale of its drink products directly to the end user or through a distributor (collectively the “customers”).

 

The Company recognizes revenues by applying the following steps in accordance with FASB Accounting Standards Codification 606 “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;
     
  ● identify the performance obligations in the contract;
     
  ● determine the transaction price;
     
  ● allocate the transaction price to performance obligations in the contract; and
     
  ● recognize revenue as the performance obligation is satisfied.

 

The Company’s performance obligations are satisfied when goods or products are shipped on a FOB shipping point basis as title passes when shipped. Our products are generally paid in advance of shipment or standard net 30 days and we offer no specific right of return, refund or warranty related to our products except for cases of defective products of which there have been none to date.

 

The Company only provides refunds for products that are damaged during delivery to the customer. However, instances of refunds are rare and have not historically had a material impact on the Company’s results of operations. Finally, the Company has made an accounting policy election to exclude from the measurement of the transaction price all taxes assessed by a governmental authority that are both imposed on and concurrent with a specific revenue-producing transaction and collected by the entity from a customer.

 

F-9
Table of Contents

 

In addition to variable consideration, the Company also provides payments to certain customers for slotting fees. In accordance with the guidance in ASC 606-10-32, the Company determined that the payment is not in exchange for a distinct good or service and it is therefore recognized as a reduction to the transaction price. As the slotting fee payment covers the life of the contract with a customer, the initial payment is recognized as an asset and is amortized as a reduction to revenue on a rational and reasonable basis over the estimated life of the contract.

 

Digital Asset Income

 

The Digital Assets Segment generates revenue through the Company’s participation in digital content and blockchain-based platforms under the Digital Asset Agreement with our affiliate, Lucky Dog Holdings.

 

On August 8, 2025, the Company entered into a revenue sharing agreement with related party, Bonk Digital, Inc. (the “Bonk Agreement”) in which the Company obtained rights to a share of future revenue streams derived from Bonk’s digital platform (the “Bonk Digital Asset”). In accordance with the guidance in ASC 805-50-30-1, ASC 350-30-25-2, ASC 55-10-45-1 and ASC 820-10-35-2, a discounted cash flow with a terminal period of 5 years and a discount rate of 15% was used to calculate the fair value of future revenues in accordance with the agreement. On December 10, 2025, the Company amended the agreement for an amount equal to 51% of all gross revenue of LetsBonk.fun. The Company and the related party can revert back to 10% of all gross revenue at a point in time which the parties agree on such terms.

 

Revenue in this segment is recognized as the underlying platform revenues are earned by Bonk and the Company’s share becomes realizable under the terms of the Bonk Agreement. The Company’s share of those revenues is based on a fixed percentage of gross receipts. As previously disclosed, the original 10% agreed upon as of August 8, 2025 was increased to 51% as of December 10, 2025.

 

Amounts earned under the Bonk Agreement are not contingent on product sales and is recognized as “Related party revenue share” in the consolidated statements of operations when:

 

● the performance obligations under the letsBonk.fun platform are satisfied,
● the transaction price (i.e., the Company’s share of platform proceeds) can be reliably measured, and
● collection is probable

 

Revenue is recorded based on gross receipts, representing the Company’s proportionate share of digital platform proceeds received or receivable during the reporting period.

 

Other Asset - Revenue Sharing Agreement

 

During the year ended December 31, 2025, the Company entered into a revenue sharing agreement (the “Agreement”) with a related party. In connection with the Agreement, the Company issued 100,000 shares of its Series C preferred stock as consideration for the counterparty’s participation in the arrangement. The Agreement entitles the counterparty to receive a portion of future revenues generated from certain Company products and initiatives, subject to the terms and conditions of the Agreement.

 

The issuance of the Series C preferred stock was accounted for as a non-cash transaction. The fair value of the Series C preferred stock issued was determined using a discounted cash flow model based on management’s estimates of future revenues expected to be generated under the Agreement. The resulting fair value was recorded as an increase to additional paid-in capital, with a corresponding amount recognized as an “Other asset” within the consolidated balance sheet as of December 31, 2025, representing the Company’s right to future economic benefit from the Agreement. As of December 31, 2025, the asset at a fair value of $2,060,968 and is amortized on a straight-line basis over 4.25 years. The Company recognized $224,019 in related amortization expense for the twelve months ended December 31, 2025. A discounted cash flow with a terminal period of 5 years and a discount rate of 15% was used to calculate the fair value of future revenues in accordance with the agreement. During the nine months ended September 30, 2026, the Company recognized $403,233 in related amortization expense.

 

F-10
Table of Contents

 

The Company will evaluate the carrying value of this asset for impairment in future reporting periods as actual revenues are realized or if other indicators of impairment arise.

 

Accounts Receivable and Credit Risk

 

Accounts receivable are generated from sales of the Company’s products. The Company provides an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. During the nine months ended September 30, 2026 and year ended December 31, 2025, the Company recognized no allowance for doubtful collections.

 

Impairment of Long-Lived Assets

 

We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

 

Goodwill and Intangible Assets

 

Goodwill is tested for impairment at a minimum on an annual basis. Goodwill is tested for impairment at the reporting unit level by first performing a qualitative assessment to determine whether it is more likely than not that the fair value of the reporting unit is less than its carrying value. If the reporting unit does not pass the qualitative assessment, then the reporting unit’s carrying value is compared to its fair value. The fair values of the reporting units are estimated using market and discounted cash flow approaches. Goodwill is considered impaired if the carrying value of the reporting unit exceeds its fair value. The discounted cash flow approach uses expected future operating results. Failure to achieve these expected results may cause a future impairment of goodwill at the reporting unit.

 

Intangible assets consist of patents and trademarks, purchased customer contracts, purchased customer and merchant relationships, purchased trade names, purchased technology, and non-compete agreements. Intangible assets are amortized over the period of estimated benefit using the straight-line method and estimated useful lives ranging from one to twenty years. No significant residual value is estimated for intangible assets. We evaluate long-lived assets (including intangible assets) for impairment whenever events or changes in circumstances indicate that the carrying amount of a long-lived asset may not be recoverable. An asset is considered impaired if its carrying amount exceeds the undiscounted future net cash flow the asset is expected to generate.

 

Research and Development

 

The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $300 and $24,190 for the nine months ended September 30, 2026 and year ended December 31, 2025, respectively.

 

Stock Based Compensation

 

The Company recognizes compensation costs to employees under FASB Accounting Standards Codification 718 “Compensation - Stock Compensation” (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share-based compensation arrangements include stock options and warrants share based payments made to non-employees for goods and services. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

 

F-11
Table of Contents

 

Income Taxes

 

The Company accounts for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on the Company’s evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in the Company’s financial statements. Since the Company was incorporated on October 24, 2018, the evaluation was performed for 2018 tax year which would be the only period subject to examination. The Company believes that its income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to its financial position. The Company’s policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

 

The Company’s deferred tax asset at September 30, 2026 and December 31, 2025 consists of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately $11,112,433 and $8,919,080, respectively. Due to the Company’s lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance of $11,112,433 and $8,919,080 for the nine months ended September 30, 2026 and year ended December 31, 2025, respectively. On August 8, 2025, the Company experienced a change in control due to the revenue sharing agreement and as a result the historical net operating loss carry forwards were eliminated.

 

Related Parties

 

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

 

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825-10-15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Segment Reporting

 

The Company has two reportable segments: (i) the dietary and energy beverage business and (ii) digital assets, consisting of investing for growth in the appreciation of the asset.

 

Gross profit (loss) is the segment performance measure the chief operating decision maker (“CODM”) (our CEO, Jarrett Boon) uses to assess the Company’s reportable segments.

 

F-12
Table of Contents

 

The dietary and energy beverage products generate revenue from the sale of these products through Amazon and other direct channels. Cost of revenue consists primarily of direct manufacturing costs and freight and shipping.

 

The digital assets have nominal costs associated with revenue generated through its revenue sharing agreement.

 

The following tables presents segment revenue and segment gross profit for the nine months ended September 30, 2026 and year ended December 31, 2025 reviewed by the CODM:

 

   Nine Months Ended
September 30
  

Year End

December 31

 
   2026   2025 
         
Revenue from beverage sales  $2,271,548   $2,117,309 
Cost of sales   2,393,534    2,691,555 
Gross profit   (121,986)   (574,246)
           
Operating expense   (5,858,700)   (35,700,558)
Impairment expense   -    (4,950,950)
Interest income   9,689    92,093 
Interest expense   (40,254)   (592,504)
Impairment of promissory note   (50,000)   - 
Other income (expense)   70,280    148,322 
Net realized gain (loss) on marketable securities   796,404    13,275,054 
Net gain (loss) on settlement   377,978    (6,140,411)
Net unrealized gain on equity investment   (190,539)   (40,542)
Net loss on exchange   -    (120,445)
Taxes   (47,248)     
Net loss from deconsolidation   (53,034)     
Loss from operations  $(5,107,410)  $(34,604,187)
           
Net loss  $(5,107,410)  $(34,604,187)

 

   Nine Months Ended
September 30
   Year End
December 31
 
   2026   2025 
         
Related party revenue share  $4,107,694   $1,812,352 
           
Operating expense   (413,000)   (25,000)
Other income (expense)   -    3,290 
Net unrealized gain (loss) on digital assets   (2,779,399)   (35,372,217)
Realized gain on receivable   1,262,843    - 
Net unrealized gain (loss) on exchange of digital assets   (7,515,268)      
Loss from operations  $(5,337,130)  $(33,581,575)
           
Net loss  $(5,337,130)  $(33,581,575)

 

F-13
Table of Contents

 

Assets and liabilities are not separately analyzed or reported to the CODM and are not used to assist in decisions surrounding resource allocation and assessment of segment performance. As such, an analysis of segment assets and liabilities has not been included in this financial information. All of the assets in these financial statements, exclusive of the digital assets are related to the dietary and energy beverage business of the Company.

 

Recent Accounting Pronouncements

 

In December 2023, the FASB, issued ASU 2023-09, Income Taxes (Topic 740): Improvements to Income Tax Disclosures. This standard expands annual income tax disclosures to require specific categories in the rate reconciliation table to be disclosed using both percentages and reporting currency amounts and requires additional information for reconciling items that meet a quantitative threshold. Additionally, the amendment requires disclosure of income taxes paid by jurisdiction. The provisions of the standard are effective for annual periods beginning after December 15, 2024. Early adoption is permitted. The amendments should be applied on a prospective basis. Retrospective application is permitted. The Company adopted the new standard on December 31, 2025.

 

Note 3 - Accounts Receivable and Note Receivables

 

At September 30, 2026 and December 31, 2025, the Company had accounts receivable of $63,632 and $90,140, respectively. At September 30, 2026 the accounts receivable was from current customers and a note receivable of $6,064,379.

 

On September 9, 2026, the Company entered into a credit collar arrangement (the “Arrangement”) with STS Digital Ltd, (“STS”). STS is a Bermuda company licensed under the Digital Asset Business Act of 2018. The Arrangement was entered into under the Client Master Trading Agreement (“MTA”) between the Company and STS dated July 31, 2026.

 

Under the Arrangement, the Company transferred 1,600,001,000,000 BONK tokens to the STS (the “Collateral”). The fair value on the date of the BONK tokens transfer is $4,801,536. In return, the Company received a loan of $3,000,000 paid in USDC (the”Loan”), equal to 60% of the initial value of the Collateral. The initial value was based on a seven day TWAP of $.0000031417 per BONK. The loan bears no stated interest and matures on September 9, 2027.

 

Under the MTA, STS may use and rehypothecate the Collateral, including transferring title to third parties. The Company’s right is limited to the return of an equivalent quantity of BONK. The Company therefore concluded that control of the Collateral transferred to STS. It derecognized the BONK and recognized a receivable from STS for the return of an equivalent quantity of BONK (the “BONK Receivable”).

 

The BONK receivable is measured at the fair value of the equivalent BONK, with changes recognized in unrealized gain (loss) in digital assets, net. The Company elected the fair value option under ASC 825-10 for the BONK receivable.

 

On September 9, 2026, the BONK Receivable was recognized at its fair value of $4,801,536, based on the fair value of the equivalent quantity of BONK tokens pledged as Collateral on that date. At September 30, 2026, the BONK Receivable was remeasured at its fair value of $6,064,379, resulting in an unrealized gain of $1,262,843 for the period. The increase in fair value from inception to September 30, 2026 reflects the change in the quoted market price of BONK tokens during the period, consistent with the Company’s election of the fair value option under ASC 825-10.

 

Note 4 – Digital Assets

 

The Company holds its digital assets primarily with FalconX, a third-party custodial platform, in accounts maintained in the name of its wholly owned subsidiary, Bonk Holdings, LLC.

 

Digital asset revenues are generated through on-chain activity and are programmatically distributed to wallets designated for the Company’s benefit. In certain instances, due to technical limitations of the custodial platform, digital assets were temporarily routed through an intermediary wallet prior to transfer to the Company’s custodial accounts. These intermediary wallets function solely as pass-through mechanisms to facilitate settlement. For a short period during the year ended December 31, 2025, the Company used an intermediary wallet to hold its digital assets while transitioning the treasury asset account from a trading account to a custody account. As of December 31, 2025, the custody account, which is under full control of the Company, has been created and all of the digital assets which were held within the intermediary accounts have been transferred from the intermediary account to the Company custody account.

 

Access to the Company’s custodial accounts is controlled by the Company through a multi-signature authorization framework requiring approval from multiple members of management. The Company retains beneficial ownership of all digital assets throughout the transaction lifecycle.

 

The following table provides a roll-forward of digital assets measured at fair value on a recurring basis for the nine months ended September 30, 2026 from year ended December 31, 2025:

 

   Fair Value 
Balance as of December 31, 2025  $17,975,241 
Related party revenue share   4,107,694 
Fair value of digital assets sold   (3,607,961)
Conversion of WSOL to SOL   - 
Fair value of digital assets exchanged to secure loan payable   (4,801,536)
Accounts Receivable excluded from fair value calculation   (10,541)
Realized gain (loss) on exchange of digital assets   (7,515,268)
Change in fair value of Digital Assets   (2,779,399)
Balance as of September 30, 2026  $3,368,230 

 

During the nine months ended September 30, 2026, and ended September 30, 2025, the Company recognized an unrealized loss from remeasurement of digital assets of $2,779,399 and $7,213,473 respectively.

 

F-14
Table of Contents

 

The following table presents the Company’s Digital Asset holdings as of September 30, 2026, and December 31, 2025:

 

September 30, 2026  Quantity   Cost Basis   Fair Value 
Bonk   868,729,255,292   $44,410,277   $3,292,484 
USD1   63,151    63,151    63,095 
SOL   8    944    999 
WSOL   98    11,648    11,652 

 

December 31, 2025  Quantity   Cost Basis   Fair Value 
Bonk   2,323,460,885,402   $55,603,463   $17,344,636 
USD1   498,056    497,667    497,677 
USDC   104,288    104,263    104,263 
SOL   231    48,313    28,665 

 

Note 5 – Fair Value Measurements

 

The Company measures certain assets and liabilities at fair value. The Company defines fair value as the price that would be received from selling an asset or paid to transfer a liability (i.e., an ‘exit price’) in the principal or most advantageous market in an orderly transaction between market participants at the measurement date.

 

Fair value is estimated by applying the following hierarchy, which prioritizes the inputs used to measure fair value into three levels and bases the categorization within the hierarchy upon the lowest level of input that is available and significant to the fair value measurement:

 

Level 1 – Valuations based on unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

 

Level 2 – Valuations based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.

 

Level 3 – Valuations based on inputs that are generally unobservable and typically reflect management’s estimate of assumptions that market participants would use in pricing the asset or liability.

 

The Company’s digital assets measured at fair value, which include assets held in Treasury and deployed in DeFi protocols are accounted for in accordance with ASC 350-60. The Company’s digital assets are valued using quoted prices in active markets for the underlying tokens, primarily on major digital-asset exchanges which represent Level 1 inputs within the fair-value hierarchy.

 

The following tables present the Company’s digital assets that are measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy of those assets as of September 30, 2026, and December 31, 2025.

 

September 30, 2026  Balance  

Quoted Prices

in Active

Markets

Level 1

  

Significant

Observable

Inputs

Level 2

  

Significant

Unobservable

Inputs

Level 3

 
Fair Value                
September 30, 2026  Balance  

Quoted Prices

in Active

Markets

Level 1

  

Significant

Observable

Inputs

Level 2

  

Significant

Unobservable

Inputs

Level 3

 
                 
BONK  $3,292,484   $3,292,484   $-   $- 
USD1   63,095    63,095    -    - 
SOL   999    999    -    - 
WSOL   11,652    11,652    -    - 
Total   3,368,230    3,368,230    -    - 

 

                 
December 31, 2025  Balance             
                 
BONK  $17,344,636   $17,344,636   $-   $- 
USD1   497,677    497,677    -    - 
USDC   104,263    104,263    -    - 
SOL   28,665    28,665    -    - 
Total   17,975,241    17,975,241    -    - 

 

The following table presents the Company’s BONK receivable measured at fair value on a recurring basis and the Company’s estimated level within the fair value hierarchy as of September 30, 2026 and December 31, 2025.

 

September 30, 2026  Balance   Level 1   Level 2   Level 3 
Fair Value                
       Quoted Prices in Active Markets   Significant Observable Inputs   Significant Unobservable Inputs 
September 30, 2026  Balance   Level 1   Level 2   Level 3 
                 
BONK Receivable  $6,064,379   $     -   $    -   $6,064,379 
Total   6,064,379    -    -    6,064,379 

 

December 30, 2025  Balance   Level 1   Level 2   Level 3 
December 31, 2025   Balance                 
                    
BONK Receivable  $-   $-   $-   $- 
Total   -    -    -    - 

 

F-15
Table of Contents

 

Note 6 - Prepaid Expenses and Deposits

 

At September 30, 2026, the Company had prepaid expenses and deposits totaling $900,134, consisting of $38,340 of dues and subscriptions, $666,455 of prepaid insurance, $3,495 of security deposits, and $191,844 of deposits on raw materials. At December 31, 2025, the Company had prepaid expenses and deposits of $1,839,484, consisting of $166,528 of raw materials, prepaid insurance of $1,509,722, security deposits of $22,897 and other prepaids of $140,337.

 

Note 7 - Inventory

 

At September 30, 2026, the Company had inventory of $284,018 consisting of finished goods. At December 31, 2025, the Company had inventory of $949,275, consisting of $118,934 of raw materials and packaging supplies and $830,341 of finished goods.

 

Note 8 – Acquisitions

 

Acquisition of Yerbaé

 

On June 27, 2025, the Company completed the acquisition of Yerbaé, a premium energy beverage company, in a transaction accounted for as a business combination under ASC 805, Business Combinations. The acquisition supports Safety Shot’s strategic growth in the functional beverage market. The Company acquired 100% of the equity interests of Yerbaé in exchange for a combination of cash and equity. The total purchase consideration was approximately $6.0 million, comprised of 19,881,948 common shares at a fair value of $0.301, or the stock price of the Company as of the acquisition date.

 

The acquisition was funded through newly issued shares of the Company’s common stock. The following table summarizes the allocation of the total purchase consideration to the assets acquired and liabilities assumed, based on their estimated fair values as of the acquisition date:

 

   June 27, 2025   Measurement
Period
Adjustments
   December 31, 2025 
Fair value of consideration paid (through issuance of common stock)  $5,984,466        $5,984,466 
                
Net liabilities acquired   (9,484,014)   (91,698)   (9,575,712)
Intangibles acquired   2,874,300    (1,461,900)   1,412,400 
Goodwill   12,594,180    1,553,598    14,147,778 
Total consideration  $5,984,466   $-   $5,984,466 

 

The excess of the purchase price over the fair value of net assets acquired was recorded as goodwill. Goodwill primarily represents expected synergies, brand recognition, and the assembled workforce. None of the goodwill is expected to be deductible for tax purposes. The Company completed the purchase price allocation within the measurement period. Transaction-related costs of approximately $500,000 were expensed as incurred and are included in general and administrative expenses on the Company’s condensed consolidated statements of operations for the three and six months ended June 30, 2025.

 

Note 9 - Marketable Securities

 

Tron Inc.

 

As of December 31, 2025, the Company held 47,142 of Tron’s common stock, which are considered marketable securities and had a fair value of $0.1 million. During the nine months ending September 30, 2026 the Company continues to hold 47,142 of Tron’s common stock, which are considered marketable securities and had a fair value of $66,942.

 

Caring Brands Inc.

 

As of December 31, 2025, the Company had a balance of 1,600,000 shares of Caring Brands Inc common stock remaining. During the nine months ended September 30, 2026, the Company entered into four stock purchase agreements dated March 20, 2026 (the “Stock Purchase Agreement”) between the company and four institutional investors. Pursuant to the Stock Purchase Agreement, the Company sold an aggregate total of 1,596,000 of Caring Brands Inc common stock for an aggregate total of $798,000, resulting in a gain of marketable securities of $796,404. In addition, the Company entered into four Promissory Notes, with each institutional investor for payment on the Stock Purchase Agreements that has a Maturity Date of July, 30, 2026. On September 30, 2026, the Company entered into a recission agreement with one of the investors to retrieve back 399,000 shares of Caring Brands Inc. As of September 30, 2026, the Company has a balance of 403,000 shares of Caring Brands Inc common stock remaining.

 

F-16
Table of Contents

 

Note 10 - Loans to Affiliates

 

During the nine months ended September 30, 2026 and year ended December 31, 2025 the Company had loans to affiliates Caring Brands Inc. of $54,405 and Elite Health Partners of $85,000, totaling $139,405.

 

Note 11 - Intangible Assets and Goodwill

 

The Company’s intangible assets consist of the following:

 

  

Gross

Carrying

Amount

  

Accumulated

Amortization

  

Net

Carrying

Amount

September 30,

2026

  

Gross

Carrying

Amount

  

Accumulated

Amortization

  

Net

Carrying

Amount

December

31, 2025

 
Yerbaé tradename and trade secrets  $1,298,600   $(108,214)   1,190,386   $1,298,600   $(43,287)  $1,255,313 
Yerbaé non-competes   113,800    (113,800)   -    113,800    (75,866)   37,934 
Total   1,412,400    (222,014)   1,190,386    1,412,400    (119,153)   1,293,247 

 

Amortization expense for the nine months ended September 30, 2026 and December 31, 2025 was $102,861 and $119,153, respectively.

 

The following table summarizes the useful lives of the Company’s intangible assets:

 

   Useful Life 
Yerbaé tradename and trade secrets   15 
Yerbaé non-competes   0.75 

 

Future amortization of intangible assets as of December 31, 2025 is as follows:

 

   Amortization 
2026   124,507 
2027   86,573 
2028   86,573 
2029   86,573 
2030   86,573 
Thereafter   822,448 

 

During the twelve months ended December 31, 2025, the Company identified a triggering event requiring analysis of the Company’s patents. The Company determined the patents were impaired and recognized impairment expense of $4,950,950 during the twelve months ended December 31, 2025.

 

On August 8, 2025, the Company entered into a revenue sharing agreement with a related party pursuant to which it obtained the right to receive 10% of the gross revenue generated by LetsBonk.fun in perpetuity in exchange for the issuance of Series C Preferred Stock. The counterparty to the arrangement is a related party through common ownership and governance.

 

On December 3, 2025, the Company announced that its revenue participation interest in LetsBonk.fun had increased from 10% to 51%. The Company accounts for the arrangement based on the contractual participation rights in effect during the reporting period. On December 10, 2025 the increase in revenue participation was consummated. In relation to this increase, the Company transferred no consideration to the related party.

 

F-17
Table of Contents

 

The Company has recorded this arrangement as an intangible asset, which is amortized over its estimated useful life of 4.25 years. Related party revenue sharing as of nine months ended September 30, 2026 and year ended December 31, 2025 totaled $1,657,735 and $2,060,968 respectively.

 

As of September 30, 2026 and December 31, 2025, goodwill totaled $14,147,778 and $14,147,778, respectively.

 

Note 12– Accrued Interest and Liabilities

 

At September 30, 2026 and December 31, 2025, the Company had accrued liabilities totaling $1,693,326 and $3,152,544, which consisted of accrued interest, credit card payables, advances, and payroll accruals. Also included in accrued liabilities as of September 30, 2026 is unearned revenue of $127,505 which consist of prepayments from customers in beverage.

 

Note 13 – Convertible Notes Payable

 

On January 20, 2025 the Company entered into a convertible note agreement with Bigger Capital LLP (i) a secured convertible note in the principal amount of $1,750,000 maturing on December 31, 2026 (the “Secured Convertible Note”); and (ii) a convertible note in the principal amount of $3,500,000 maturing July 21, 2025 (the “Convertible Note,” and, together with the Secured Convertible Note, the “Notes”). The notes entered were due to a legal settlement and no cash was received. On June 12, 2025, Bigger sold the notes to Trajan and Fried. The sale had no impact on the Company’s outstanding balance. During the twelve months ended December 31, 2025, the holders of the note converted principal of $5,200,000 and interest of $208,525 to 7,212 shares of Preferred B stock. Prior to the conversion, $50,000 of the principal was paid by the Company. The balance of these convertible notes was $0 as of December 31, 2025.

 

Exchange Agreement

 

On July 2, 2025, the Company entered into an Exchange Agreement (the “Exchange Agreement”) with certain investors (the “Investors”). Pursuant to the Exchange Agreement, the Investors exchanged (i) the Secured Convertible Note and (ii) the Convertible Note previously issued by the Company for an aggregate of 7,212 shares of the Company’s Series B Preferred Stock. The exchange was accounted for as an extinguishment of debt in accordance with ASC 470-50, Debt — Modifications and Extinguishments, as the terms of the new instruments were substantially different from those of the original notes. The carrying amount of the extinguished notes, including any unamortized discount or deferred costs, was derecognized, and the Series B Preferred Stock was recorded at its fair value on the date of exchange. The difference between the carrying amount of the notes and the fair value of the preferred shares issued was recognized as an increase to additional paid-in capital.

 

On January 20, 2025 the Company entered into a convertible note agreement with Bigger Capital LLP (i) a secured convertible note in the principal amount of $1.75 million maturing on December 31, 2026 (the “Secured Convertible Bigger Note”); and (ii) a convertible note in the principal amount of $3.5 million maturing June 30, 2025 (the “Convertible Bigger Note,” and, together with the Secured Convertible Bigger Note, the “Bigger Notes”). The notes entered were due to a legal settlement and no cash was received. This amount was recorded as a loss on settlement.

 

The following table sets forth a summary of the principal balances of the Company’s convertible promissory notes activity for the year ended December 31, 2025:

  

Principal Balance, December 31, 2024   5,250,000 
Note converted to Preferred B stock   (5,250,000)
Principal Balance, December 31, 2025   - 

 

As of September 30, 2026, the Company has no convertible note payables.

 

Note 14 – Note Payable STS Digital

 

On September 9, 2026, the Company entered into a credit collar arrangement (the “Arrangement”) with STS Digital Ltd, (“STS”). STS is a Bermuda company licensed under the Digital Asset Business Act of 2018. The Arrangement was entered into under the Client Master Trading Agreement (“MTA”) between the Company and STS dated July 31, 2026.

 

Under the Arrangement, the Company transferred 1,600,001,000,000 BONK tokens to the STS (the “Collateral”). The fair value on the date of the BONK tokens transfer is $4,801,536. In return, the Company received a loan of $3,000,000 paid in USDC (the”Loan”), equal to 60% of the initial value of the Collateral. The initial value was based on a seven day TWAP of $.0000031417 per BONK. The loan bears no stated interest and matures on September 9, 2027.

 

Note 15 – Covid-19 SBA Loans

 

During the year ended December 31, 2020, the Company applied for and received $55,700 under the Economic Injury Disaster Loan Program (“EIDL”), which is administered through the Small Business Administration (“SBA”). During 2021, the SBA notified the Company that the terms of the EIDL are a term of 30 years and an interest rate of 3.75%. The balance of the EIDL at September 30, 2026 and December 31, 2025 was $50,476 and $49,210, respectively.

 

Note 16 - Capital Structure

 

Preferred Stock

 

The Company is authorized to issue a total of 1,000,000 shares of preferred stock with par value of $0.001. The Company’s Preferred Stock provides holders the right to receive dividends, when, as, and if declared, on an as-converted-to-common-stock basis and in the same form as dividends paid on common stock, excluding dividends in the form of common stock which are governed by the Certificate of Designation. The Preferred Stock is voting stock, with holders entitled to vote together with common stockholders on an as-converted basis, with one vote for each share of common stock into which the Preferred Stock is then convertible, subject to limitations set forth in the Certificate of Designation. In the event of any liquidation, dissolution, or winding up of the Company, distributions will be made to holders of Preferred Stock and common stock pro rata based on the number of shares held, treating all Preferred Stock as if converted to common stock immediately prior to such event and without regard to any conversion limitations, subject to adjustment for certain corporate events, including stock dividends and splits, subsequent equity sales, rights offerings, pro rata distributions, and fundamental transactions, as defined in the Certificate of Designation.

 

F-18
Table of Contents

 

Series A Preferred Stock

 

On May 2, 2025, the Company filed a Certificate of Designation with the Delaware Secretary of State designating, 61,949 shares as Series A-1 Convertible Preferred Stock, 17,401 shares as Series A-2 Convertible Preferred Stock, 20,650 shares as Series A-3 Convertible Preferred Stock (all such series of preferred stock referred to herein collectively as “Series A Preferred Stock”), each with a stated value of $750 per share. The Certificate of Designation sets forth the rights, preferences and limitations of the shares of Series A Preferred Stock.

 

The Series A Preferred Stock is convertible, at the option of the holder, into shares of the Company’s common stock at a fixed conversion price of $4.3935 per share, subject to adjustment for stock splits, stock dividends and similar events. Holders of the Series A Preferred Stock are entitled to dividends equal, on an as-if-converted-to-common-stock basis, to the dividends actually paid on shares of common stock when, as and if declared. The Series A Preferred Stock is voting stock: holders are entitled to vote together with the common stock on an as-converted basis (one vote per share of common into which their Series A shares are convertible). Upon any liquidation event, the assets available for distribution will be distributed among the holders of Preferred Stock and the common stock pro-rata based on the number of shares held and treating the Series A shares as if converted into common stock immediately prior to liquidation, without regard to any conversion limitations.

 

On May 2, 2025, the Company entered into an exchange agreement with Core 4 Capital Corp., a related party, and converted 6,575,025 shares of common stock to 39,933 shares of preferred stock. The Company believes the terms of these transactions are comparable to those that could be obtained from unrelated third parties; however, because the transactions are with related parties, they may not be the result of arm’s-length negotiations. All related party balances are unsecured, non-interest bearing, and due on demand unless otherwise noted. The Company used a third party’s calculations to value the Series A preferred stock. The third party used the option pricing model to calculate a $76.00 per preferred A share or $3,034,908. The fair value of the common stock exchanged on May 2, 2025 was $.4799 per common share or $3,155,354, resulting in a loss on the exchange of $120,446 taken on the income statement.

 

Pursuant to the Exchange Agreement dated May 2, 2025, the Company issued the remaining 60,067 shares of Series A Preferred Stock to Core4 Capital Holdings Corp, a related party, effective September 30, 2026, completing the 100,000 shares authorized under the Certificate of Designation filed May 2, 2025. Of these shares, 22,016 were issued as Series A-1 Convertible Preferred Stock in exchange for the cancellation of 103,571 shares of the Company’s common stock, and 17,401 and 20,650 shares were issued as Series A-2 Convertible Preferred Stock and Series A-3 Convertible Preferred Stock, respectively, in exchange for the cancellation of 179,005 warrants to purchase shares of the Company’s common stock, as further described in Note 17 – Warrants and Options. The Company used a third party’s calculations to value the Series A Preferred Stock issued in this exchange. The third party used the option-pricing model to calculate a fair value of $24.91 per Series A preferred share, or $1,496,269 in aggregate for the 60,067 shares issued. The fair value of the 103,571 shares of common stock and 179,005 warrants exchanged was $205,071 and $176,821, respectively, or $381,891 in aggregate. In accordance with ASC 815-40, the exchange of the equity classified warrants and common stock for the Series A Preferred Stock was accounted for as a modification/exchange of equity classified instruments, with the effect recorded within additional paid in capital and no gain or loss recognized in the consolidated statements of operations. The $1,114,378 excess of the fair value of the Series A Preferred Stock issued over the fair value of the common stock and warrants surrendered was treated as a deemed dividend, which reduces net income (loss) attributable to common stockholders in the computation of earnings per share for the three and nine months ended September 30, 2026.

 

On September 4, 2026, the Company entered into a Preferred Stock Redemption Agreement (the “Redemption Agreement”) with Core4 Capital Corp (“Core4”), an Ohio corporation, a related party. Following the completion of the Series A-1, Series A-2 and Series A-3 issuances described above, Core4 was the holder of 100,000 Preferred Series A Shares of Stock (the “Preferred Shares”) of the Company. Pursuant to the terms of the Redemption Agreement, the Company purchased from Core4 26,667 of the Preferred Shares for an aggregate purchase price (the “Purchase Price”) of Four Million Dollars ($4,000,000.00), payable via wire transfer within three (3) business days of the execution of the Redemption Agreement. The wire payable was paid in full and the transaction was recorded effective September 30, 2026.

 

Following the consummation of the transactions pursuant to the Redemption Agreement, Core4 holds 73,333 Preferred Shares and in the event of a merger, may convert the 73,333 Preferred Shares to 1,516,873 shares of Common Stock of the Company.

 

As part of the consideration for the Purchase Price, Core4 has agreed to irrevocably waive all anti-dilution rights with respect to the Preferred Shares and all rights under the Certificate of Designation of Preferences, Rights and Limitations of Series A Convertible Preferred Stock filed on May 2, 2025, including voting rights, liquidation preferences, and conversion rights. Core4 has also agreed to a general release of claims against the Company arising from Core4’s investment in the Company. The Company had 100,000 shares of Series A preferred stock issued, 26,667 of which are held in Treasury, resulting in 73,333 and 39,933 of Series A preferred stock outstanding as of September 30, 2026 and December 31, 2025.

 

Series B Preferred Stock

 

On July 2, 2025, the Company filed a Certificate of Designation with the Delaware Secretary of State designating 10,000 shares of its Series B Convertible Preferred Stock (the “Series B Preferred Stock”), each with a stated value of $750 per share. The Certificate of Designation sets forth the rights, preferences and limitations of the shares of Series B Preferred Stock.

 

The Series B Preferred Stock is convertible, at the option of the holder, into shares of the Company’s common stock at a fixed conversion price of $0.34 per share, subject to adjustment for stock splits, stock dividends and similar events. Holders of the Series B Preferred Stock are entitled to dividends equal, on an as-if-converted-to-common-stock basis, to the dividends actually paid on shares of common stock when, as and if declared. The Series B Preferred Stock is voting stock: holders are entitled to vote together with the common stock on an as-converted basis (one vote per share of common into which their Series B shares are convertible). Upon any liquidation event, the assets available for distribution will be distributed among the holders of Series A Convertible Preferred Stock, Series B Preferred Stock and the common stock pro-rata based on the number of shares held and treating the Series B shares as if converted into common stock immediately prior to liquidation, without regard to any conversion limitations. The company used a third party’s calculations to value the Series B preferred stock. The third party used the option pricing model to calculate a $564 per preferred B share or $4,063,962. The cash value of the convertible note was $5,408,525, resulting in difference of $1,344,563 on the extinguishment. The difference was credited to additional paid in capital.

 

During the year ended December 31, 2025, certain holders of our Preferred B Shares gave notice of conversion to convert 5,399 Preferred B shares to common stock, resulting in the issuance of 340,273 shares of common stock.

 

In April of 2026 the last holder of our Preferred B Shares gave a notice of conversion to convert 1,813 Preferred B shares to common stock, resulting in the issuance of 114,625 shares of common stock. The Company had 0 and 1,813 of Series B preferred stock outstanding as of September 30, 2026 and December 31, 2025.

 

F-19
Table of Contents

 

Series C Preferred Stock

 

On August 8, 2025, the Company entered into a Securities Purchase Agreement (the “August Purchase Agreement”) with an institutional investor entity (the “Investor”) for a private investment in public equity (the “PIPE Offering”) of 35,000 shares of its Series C Convertible Preferred Stock, par value $0.001 per share (the “Series C Preferred Stock”), convertible into 62,701,541 shares of common stock, par value $0.001 (the “Common Stock”), at a conversion price of $0.5582 per share of Common Stock. The 35,000 shares of Series C Preferred Stock are referred to herein as the “SPA Preferred Stock Shares.”

 

The Investor paid the $25 million purchase price for the SPA Preferred Stock Shares in the form of BONK tokens (the “Consideration Tokens”), based on the closing price of BONK tokens on August 10, 2025. The Consideration Tokens are held in the custodian wallet account designated and controlled by the Company’s Board of Directors (the “Board”).

 

On August 8, 2025, the Company also entered into a Revenue Sharing Agreement (the “Revenue Sharing Agreement”) with the Investor, pursuant to which the Company agreed to issue 100,000 shares of the Series C Preferred Stock, convertible into 5,118,493 shares of Common Stock at a conversion price of $0.5582 per share of Common Stock, in exchange for an amount equal to 10% of all gross revenue of LetsBonk.fun in perpetuity. The 100,000 shares of Series C Preferred Stock are referred to herein as the “RSA Preferred Stock Shares,” and the SPA Preferred Stock Shares and the RSA Preferred Stock Shares are collectively referred to herein as the “Preferred Stock Shares.” The Company recorded an asset representing the revenue sharing aggregate using a discounted cash flow analysis. As of December 31, 2025, the asset had a net value of $2,060,968 and is included in the accompanying consolidated balance sheet as an ‘other asset’. The asset is amortized over 4.25 years.

 

The Preferred Stock Shares cannot be converted into more than 19.99% of the currently outstanding shares of Common Stock until stockholder approval of such an issuance is obtained.

 

The conversion price and number of shares of Common Stock issuable upon conversion of the Preferred Stock Shares is subject to appropriate adjustment in the event of stock splits and subsequent rights offerings. There is no trading market available for the Preferred Stock Shares on any securities exchange or nationally recognized trading system. The Company does not intend to list the Preferred Stock Shares on any securities exchange or nationally recognized trading system.

 

The securities being offered and sold by the Company under the August Purchase Agreement and the Revenue Sharing Agreement have not been registered under the Securities Act and may not be offered or sold in the United States absent registration with the SEC or an applicable exemption from such registration requirements. The securities were offered only to accredited investors.

 

Pursuant to the August Purchase Agreement and the Revenue Sharing Agreement, on August 11, 2025, the Company filed a Certificate of Designation of Series C Preferred Stock with the Secretary of State of the State of Delaware (the “Series C Certificate of Designation”).

 

The stated value of the Series C Preferred Stock is $1,000 per share.

 

Holders of the Preferred Stock Shares are entitled to cast the number of votes equal to the number of whole shares of Common Stock into which the shares of Series C Preferred Stock are convertible on the basis of a conversion price of $1.00. The Holders shall vote together with the holders of shares of Common Stock as a single class. The Preferred Stock Shares cannot be voted on an “as converted basis” of more than 19.99% of the currently outstanding shares of Common Stock until shareholder approval of such voting rights is obtained.

 

Holders shall be entitled to receive, and the Company shall pay, dividends on Preferred Stock Shares equal (on an as-if-converted-to-Common-Stock basis) to and in the same form as dividends actually paid on shares of the Common Stock when, as and if such dividends are paid on shares of the Common Stock.

 

Upon any liquidation, dissolution or winding-up of the Company, the holders of Preferred Stock Shares shall be entitled to receive out of the assets of the Company the same amount that a holder of Common Stock would receive if the Preferred Stock Shares were fully converted (disregarding for such purposes any conversion limitations hereunder) to Common Stock which amounts shall be paid pari passu with all holders of Common Stock.

 

In the event that LetsBonk.fun ceases operations on or prior to the six-month anniversary of the original issuance date of the Preferred Stock Shares, then 50% of the Preferred Stock Shares issued shall be subject to automatic rescission and shall be returned to the Company for cancellation without further action by the Investor or the Company.

 

At all times when the Series C Preferred Stock remains issued and outstanding, (1) the holders of record of the shares of Series C Preferred Stock, exclusively and voting together as a separate class on an as-converted to Common Stock basis, shall be entitled to elect 50% of the directors of the Company (the “Preferred Directors”); and (2) the holders of record of the shares of Common Stock and of any other class or series of voting stock, exclusively and voting together as a single class on an as-converted to Common Stock basis, shall be entitled to elect the balance of the total number of directors of the Company (the “At-Large Directors”). If the holders of shares of the Series C Preferred Stock fail to elect a sufficient number of directors to fill all directorships for which they are entitled to elect directors, then any directorship not so filled shall remain vacant until such time as the holders of the Series C Preferred Stock fill such directorship.

 

The Company and the Holders acknowledge and agree that the Company is entitled to receive 10% of all gross revenue generated by LetsBonk.fun (the “LB Interest”), as set forth in that certain Revenue Sharing Agreement. The rights of the Company to receive revenue under this Section are contractual rights derived through and governed by the Revenue Sharing Agreement and are not dividend rights under Delaware corporate law. In the event that LetsBonk.fun ceases operations on or prior to the six-month anniversary of the original issuance date of the Series C Preferred Stock (“Triggering Event”), then 50% of the Series C Preferred Stock issued shall be subject to automatic rescission and shall be returned to the Company for cancellation without further action by the Holder or the Company.

 

F-20
Table of Contents

 

Common Stock

 

The Company is authorized to issue a total of 1,000,000,000 shares of common stock with par value of $0.001. As of September 30, 2026 and December 31, 2025 there was 7,943,083 and 7,751,707 shares of common stock issued and outstanding, respectively.

 

The following table summarizes the issuances of the Company’s shares of common stock for the nine months ended September 30, 2026:

 

      
Balance December 31, 2025  $7,751,707 
Common stock issued from stock payable   117,943 
Balance March 31, 2026  $7,869,650 
Common stock issued for stock base compensation   17,857 
Preferred stock converted to common   114,625 
Pre-split common stock adjustment   -1,192 
Balance, June 30, 2026  $8,000,940 
Common stock issued from stock payable   45,714 
Common stock converted to preferred   -103,571 
Balance, September 30, 2026  $7,943,083 

 

Common Stock Payable

 

The following table summarizes the activity of the Company’s common stock payable for the nine months ended September 30, 2026:

 

      
Balance, December 31, 2025  $2,501,336 
Shares issued for common stock payable   (1,532,536)
Shares due for services   16,800 
Shares issued for services   (131,400)
Shares issued for bonuses   (445,000)
Balance, September 30, 2026  $409,200 

 

F-21
Table of Contents

 

Note 17 - Warrants and Options

 

Warrants

 

During the year ended December 31, 2024, the Company reached a settlement with Bigger Capital Fund LP, (“Bigger”) for a resolution to all issues and claims that relate to the previously filed action against the Company in the Supreme Court of the State of New York, New York County, Index No. 65018/2024. Under the terms of the Settlement the Company agreed to cancel 1,656,050 original warrants with an exercise price of $1.40 held by Bigger in exchange for 5,332,889 “exchange” warrants with an exercise price of $0.4348. The fair value of the exchange warrants is $2,732,329 which is offset by the unamortized value of $439,028 of the original warrants.

 

               Market         
   Relative           Price on         
   Fair   Term   Exercise   Grant   Volatility   Risk-free 
Reporting Date  Value   (Years)   Price   Date   Percentage   Rate 
1/17/25  $2,732,329    5   $0,4348   $0,5435    161%   0.0442 

 

The following table summarize all warrants outstanding as of September 30, 2026 and December 31, 2025, and the related changes during the period. Exercise price is the weighted average for the respective warrants at end of period. Both the amount of warrants and their weighted average exercise price reflect the 1 for 35 split that was effected during December of 2025.

 

   Number of Warrants   Weighted Average
Exercise Price
 
Balance at December 31, 2025   685,254   $59.57 
Warrants issued   -      
Warrants exchanged for Preferred A Stock   (179,005)     
Warrants expired/forfeited   (338,423)     
Outstanding at September 30, 2026   167,826   $61.27 
           
Exercisable at September 30, 2026   167,826   $61.27 

 

Pursuant to the Preferred Stock Redemption Agreement, dated September 4, 2026, with Core4 Capital Corp, (“Core4”), Core4 exchanged 179,005 warrants to purchase shares of the Company’s common stock for 38,051 shares of the Company’s Series A preferred stock. The fair value of the 179,005 warrants exchanged for Series A-2 and Series A-3 Preferred Stock was estimated using the Black-Scholes option-pricing model. The expected term for each tranche is the remaining contractual life of the warrants from the September 30, 2026 valuation date to their respective contractual expiration dates. Expected volatility and the risk-free interest rate were sourced from the same third-party valuation report used to value the Series A Preferred Stock issued in the exchange (see Note 16 – Series A Preferred Stock), and the Company assumed a 0% dividend yield, consistent with its history of not paying dividends on its common stock. The exercise price used for each tranche reflects the original exercise price as adjusted for the 1-for-35 reverse stock split effected in December 2025. The assumptions used and the resulting fair value by warrant tranche are as follows:

 

Reporting Date  Stock Price  Exercise Price  Remaining Term (Years)  Volatility  Risk-free Rate
9/30/2026  $1.98   $14.35 - $31.15   2.95    139.24%   4.88%

 

During the nine months ended September 30, 2026, 338,423 warrants expired/forfeited unexercised in accordance with their original terms.

 

Stock Options

 

The following table summarizes all stock options outstanding as of September 30, 2026 and December 31, 2025, and the related changes during the period. Exercise price is the weighted average for the respective stock options at end of period. Both the amount of stock options and their weighted average exercise price reflect the 1 for split that was effected during December of 2025.

 

       Weighted Average 
   Number of Shares   Exercise Price 
Outstanding at December 31, 2025   531,199   $48.19 
Granted   -    - 
Exercised   -    - 
Forfeited or expired   (104,710)  $- 
Outstanding at September 30, 2026   426,489   $49.03 

 

F-22
Table of Contents

 

During the year ended December 31, 2025, the Company granted a total of 111,309 five-year options to employees of the Company of which 16,142 have vesting schedule from one to three years with an exercise price between $12.95, $22.02 and 28,535 which vested immediately upon grant with exercise prices between $11.55 and $17.15, 7,143 options which vest over varying schedules through 2026 at an exercise prices of $15.75. Additionally, the Company granted 52,346 options with exercise prices ranging from $12.59 to $241.09 which vested immediately.

 

The fair value of these options was measured using the Black-Scholes valuation model at the grant date. The table below sets forth the assumptions for Black-Scholes valuation model on the respective reporting date. For options granted to employees, we use a plain vanilla Black-Scholes calculation to calculate fair value with standard market inputs.

 

      2025  
Expected volatility     121%-162 %
Expected dividends     -  
Expected term (in years)     2.5-5  
Risk-free rate     3.59%-4.89 %

 

During the nine months ending September 30, 2026, 104,710 of the options granted by the Company reached their time of expiration. On September 30, 2026 and December 31, 2025 the Company had 426,489 and 531,199 options outstanding, respectively.

 

Legal Proceedings.

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

On September 5, 2023, “Sabby” Volatility Warrant Master Fund Ltd. filed a lawsuit against the Company in the federal district court for the Southern District of New York case captioned Sabby Volatility Warrant Master Fund Ltd. v. Jupiter Wellness, Inc., No.1:23-cv-07874-KPF (the “Litigation”). Sabby’s initial complaint in the Litigation alleges that the Company’s delayed spin-off and distribution of the common stock of “SRM” Entertainment. Inc. give rise to claims of breach-of-contract, promissory estoppel, and negligent misrepresentation. On November 10, 2023, Jupiter sought judicial permission to move to dismiss Sabby’s complaint, arguing that Sabby had no legal right to the delayed distribution occurring on the original record date, and that regardless, no law requires the Company to compensate Sabby for the costs of covering its short position against the Company. The Litigation was dismissed with prejudice by the federal district court for the Southern District of New York on September 23, 2024. On October 10, 2024, Sabby filed an appeal of the Southern District’s dismissal to the United States Court of Appeals for the Second Circuit. In or around March of 2025, Sabby was successful in its appeal to the Second Circuit and the lower court’s ruling was overturned as to Sabby’s breach of contract claim – Sabby’s remaining claims were dismissed. On or about July 1, 2025, the Second Circuit denied the Company’s petition for reconsideration. On May 6, 2026, the Company agreed to settle the Litigation by agreeing to pay Sabby $250,000 in exchange for a dismissal of the case and a full release from any claims related to the Litigation.

 

F-23
Table of Contents

 

On February 9, 2024, “Sabby” Volatility Warrant Master Fund Ltd. sued the Company in the federal district court for the Southern District of New York, case captioned, Sabby Volatility Warrant Master Fund Ltd. v. Safety Shot, Inc., No. 1:24-cv-920-NRB (the “Litigation”). Sabby’s initial complaint alleges that the Company has improperly refused to honor Sabby’s exercise of a Warrant to acquire 2,105,263 shares of common stock. On March 8, 2024, Sabby filed an amended complaint. The Company answered the amended complaint. Sabby seeks “liquidated and compensatory damages in an amount to be proven at trial,” including compensatory damages “estimated to be at least $750,000,” liquidated damages “estimated to be at least $600,000,” specific performance, attorneys’ fees, expenses and costs. The Company does not believe that the Litigation’s ultimate disposition or resolution will have a material adverse effect on the Company’s financial position, results of operations or liquidity. The Company has made an offer of $1.5 million to settle this matter. In January of 2026 the Company participated in a trial in the Litigation as to damages only and is awaiting the Court’s ruling. The Company’s offer of $1.5 million was accrued as of December 31, 2025 and remains as an accrued expense as of September 30, 2026.

 

On or around February 4, 2026, Plaintiff Shawn Thackrah filed a putative class action in the United States District Court for the Central District of California, entitled Shawn Thackrah v.Yerbae, LLC (the “Company”), Case No. 8:26-cv-00271-MRA-KES (the “Action”). The complaint in the Action (the “Complaint”) alleged that the Company’s Yerbae’ brand energy drink products (the “Products”) were falsely and/or misleadingly advertised by stating: “Naturally Sweetened.” Plaintiff alleged that stevia leaf extract contained in the Products was an artificial sweetener ingredient. Plaintiff asserted claims on behalf of himself, and those similarly situated, under California’s Consumers Legal Remedies Act (Cal. Civ. Code § 1750, et seq.), California’s Unfair Competition Law (Cal. Bus. & Prof. Code § 17200, et seq.), and breach of express warranty (the “Claims”). The Company denied any wrongdoing or liability in the Action but in order to avoid the uncertainty, inconvenience, burden and expense of further litigation of the Claims, on or about May 13, 2026, the Company settled the case and agreed to pay Thackrah the total sum of forty-five thousand dollars $45,000 to resolve all of the Claims in the Complaint (the “Settlement Payment”). The Settlement Payment included four thousand dollars $4,000 to Plaintiff Shawn Thackrah as consideration for his release of Caims and forty-one thousand dollars $41,000 to Crosner Legal, PC as payment for Plaintiff’s attorneys’ fees and costs.

 

On July 29, 2026, the Court returned its verdict and awarded Sabby a total of $791,807.76 in damages and interest. When interest is added into the verdict, the total judgment is $950,557.44 (the “Judgment”). As the Judgment was substantially less than what the Company had accrued, the Company was able to reverse $500,000 in accrued expenses for this matter. In addition, as the Company is considered the “prevailing party” in the case, the Company plans to file a motion to recover a portion of its attorney’s fees. If the Company is successful in its motion to recover its attorney’s fees, the Judgment could be reduced further. On October 16, 2026, the Court issued its final ruling and judgment in the case in the amount of $966,114.29 owed to Sabby by the Company.

 

On January 16, 2025, Carla Olson, on behalf of herself and a putative class of similarly situated individuals, filed a Class and Representative Action against Yerbaé, LLC, in the Superior Court of the State of California for the County of San Diego, alleging, among other things, violations of various provisions of the California Labor Code, the Industrial Welfare Commission’s Wage Order No. 4 and the Private Attorneys General Act (the “Litigation”). The Plaintiff alleges, among other things, that Yerbaé wilfully misclassified brand ambassadors as independent contractors rather than employees and seeks to recover, among other things, unpaid wages, meal and rest break premiums, expense reimbursements and statutory penalties. On or about December 15, 2025, the Company agreed to settle the Litigation by agreeing to pay $75,000 in exchange for a dismissal of the case and a full release from any claims related to the Litigation.

 

On September 3, 2025, the Company has reached a settlement with Brian John, the former CEO of Jupiter Wellness, whereby Mr. John had an alleged claim for certain shares of SRM (TRON) stock (the “Settlement”). As part of the settlement, the Company agreed to give Mr. John 100,000 shares of its TRON stock. In turn, Mr. John has agreed to register 500,000 shares of the Company’s Caring Brand shares. The Settlement contains customary mutual releases of all potential claims that the parties may have against each other and covenants not to sue.

 

On or about July 29, 2025, the Company settled a dispute with Iroquois Master Fund, Ltd. and Iroquois Capital Investment Group (collectively “Iroquois”) whereby the Company agreed to pay Iroquois $2.5 million in exchange for a full release of all claims by Iroquois. (the “Dispute”). The Dispute stemmed from Iroquois alleged ownership and attempt to do a cashless exercise of certain Company stock warrants. The Company paid the settlement amount of $2.5 million in full by July 31, 2025.

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

Note 18 - Subsequent Events

 

In accordance with ASC Topic 855-10, the Company has analyzed its operations subsequent to September 30, 2026, to the date these financial statements were issued and has recognized the following material subsequent events.

 

Subsequent to September 30, 2026 the Company issued 640,000 of common shares of stock.

 

F-24
Table of Contents

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

FORWARD LOOKING STATEMENTS

 

This quarterly report contains forward-looking statements. These statements relate to future events or our future financial performance. In some cases, you can identify forward-looking statements by terminology such as “may”, “should”, “expects”, “plans”, “anticipates”, “believes”, “estimates”, “predicts”, “potential” or “continue” or the negative of these terms or other comparable terminology. These statements are only predictions and involve known and unknown risks, uncertainties and other factors that may cause our or our industry’s actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, levels of activity, performance or achievements. Except as required by applicable law, including the securities laws of the United States, we do not intend to update any of the forward-looking statements to conform these statements to actual results.

 

Our unaudited financial statements are stated in United States Dollars (US$) and are prepared in accordance with United States Generally Accepted Accounting Principles. The following discussion should be read in conjunction with our financial statements and the related notes that appear elsewhere in this quarterly report. The following discussion contains forward-looking statements that reflect our plans, estimates and beliefs. Our actual results could differ materially from those discussed in the forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to, those discussed below and elsewhere in this quarterly report.

 

In this quarterly report, unless otherwise specified, all dollar amounts are expressed in United States dollars and all references to “common shares” refer to the common shares in our capital stock.

 

As used in this quarterly report and unless otherwise indicated, the terms “we”, “us”, “our”, “BONK” and the “Company” mean Bonk, Inc.

 

Overview

 

Bonk, Inc. (NASDAQ: BNKK) was formerly known as Safety Shot, Inc., and prior to that, Jupiter Wellness, Inc.

 

In August 2023, the Company acquired certain assets of GBB Drink Lab Inc which included the blood alcohol reduction drink Sure Shot (the “Sure Shot Dietary Supplement”), an over-the-counter drink that can lower blood alcohol content to allow recovery from the effects of alcohol by supporting its metabolism. Concurrently with the acquisition, the Company changed its name to Safety Shot, Inc. and changed its NASDAQ trading symbol to “SHOT”. The Company launched the Sure Shot Dietary Supplement in December 2023.

 

On January 7, 2025, the Company entered into an Arrangement Agreement with Yerbaé Brands Corp. (“Yerbaé”), pursuant to which the Company agreed, among other things, to acquire all of the issued and outstanding common shares of Yerbaé in exchange for shares of common stock of the Company pursuant to a plan of arrangement under the Business Corporations Act (British Columbia) (the “Arrangement”). The Arrangement was consummated on June 27, 2025. Yerbaé’s principal subsidiaries are Yerbaé Brands Co. and Yerbaé LLC of which Yerbaé owns 100% interests in, together, “Yerbaé”.

 

On October 8, 2025, the Company changed its corporate name to Bonk, Inc. The name change, which became effective on the Nasdaq Capital Market under the new trading symbol “BNKK” on October 10, 2025, reflects the Company’s strategic repositioning and alignment with the BONK ecosystem and its broader focus on digital asset and decentralized finance initiatives.

 

Historically, the Company generated revenue through the sale of its Sure Shot Dietary Supplement and Yerbaé’s plant-based energy beverage products, which were distributed online and through various retail channels. During 2025, the Company began to transition its strategic focus away from beverage sales toward opportunities within the digital asset and decentralized finance sectors. The Company’s current activities are centered on developing, investing in, and participating in projects aligned with the BONK ecosystem and other blockchain-based initiatives.

 

In August 2025, the Company entered into a digital asset transaction involving Bonk tokens, a Solana-based cryptocurrency. The Company received Bonk tokens in connection with this transaction. The transaction represents the Company’s initial entry into the digital asset space and is intended to support the Company’s strategic initiatives related to digital brand engagement and emerging blockchain-based marketing opportunities.

 

The Company has discontinued certain historical product lines, which included a diverse range of products, such as hair loss treatments, vitiligo solutions, and sexual wellness products. In connection therewith, on September 24, 2024, the Company entered into a Separation and Exchange Agreement with its former subsidiary Caring Brands, Inc., whereby Caring Brands, Inc. would commercialize this product line. Caring Brands, Inc. became responsible for all costs associated with the operation of that line of business. The Company retained ownership of 3,000,000 shares of Caring Brands, Inc.

 

2
Table of Contents

 

Recent Developments

 

Basis of Presentation

 

The accompanying consolidated financial statements are presented in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and pursuant to the rules and regulations of US Securities and Exchange Commission (“SEC”). The consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries, Jupiter Wellness Investments, Inc., Yerbae Brands Inc, and Bonk Holdings, LLC. All intercompany accounts and transactions have been eliminated.

 

Equity Method for Investments

 

Investments in unconsolidated affiliates, which the Company exerts significant influence but does not control or otherwise consolidate, are accounted for using the equity method. Equity method investments are initially recorded at cost. These investments are included in investment in joint ventures in the accompanying consolidated balance sheets. The Company’s share of the profits and losses from these investments is reported in loss from equity method joint venture in the accompanying consolidated statements of operations. The Company monitors its investments for other-than-temporary impairment by considering factors such as current economic and market conditions and the operating performance of the investees and records reductions in carrying values when necessary.

 

Asset Purchases

 

The Company accounts for an acquisitive transaction determined to be an asset purchase based on the cost accumulation and allocation method, under which the costs to purchase the asset or set of assets are allocated to the assets acquired. No goodwill is recorded in connection with an asset purchase.

 

Investments in Marketable Securities

 

The Company’s Marketable Securities are considered Held-For-Trading (“HFT”) or Trading Assets. HFT securities are valued at their fair value when purchased/sold, and any unrealized gains or losses are recorded periodically on financial reporting dates as other income or loss.

 

Significant Accounting Policies and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our unaudited financial statements for the nine months ended September 30, 2026 and 2025 and audited financial statements for the year ended December 31, 2025, which have been prepared in accordance with United States generally accepted accounting principles, or U.S. GAAP, and the rules and regulations of the Securities and Exchange Commission. The preparation of the financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements as well as the reported revenue generated, and expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions and any such differences may be material. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving management’s judgments and estimates.

 

Cash and Cash Equivalents

 

The Company considers all short-term investments with a maturity of three months or less when purchased to be cash and equivalents for purposes of the statement of cash flows. There were no cash equivalents as of September 30, 2026 or December 31, 2025.

 

Net Loss per Common Share

 

Net income (loss) per common share is computed pursuant to section 260-10-45 of the FASB Accounting Standards Codification. Basic net income (loss) per share is computed by dividing net income (loss) by the weighted average number of shares of common stock outstanding during the period. If applicable, diluted earnings per share assume the conversion, exercise or issuance of all common stock instruments such as options, warrants, convertible securities and preferred stock, unless the effect is to reduce a loss or increase earnings per share. As such, options, warrants, convertible securities, and preferred stock are not considered in the calculations, as the impact of the potential common shares would be to decrease the loss per share.

 

   For the Three Months Ended September 30,   For the Nine Months Ended September 30, 
   2026   2025   2026   2025 
Numerator:                    
Net income (loss)  $(2,561,225)  $(33,581,216)  $(10,444,540)  $(25,533,204)
Less: deemed dividend on Series A Preferred stock exchange  $(1,114,378)  $-   $(1,114,378)  $- 
Net loss attributable to common stockholders  $(3,675,603)  $(33,581,216)  $(11,558,918)  $(25,533,204)
                     
Denominator:                    
Denominator for basic earnings per share - Weighted-average common shares issued and outstanding during the period   8,044,402    4,293,869    7,977,166    2,891,519 
Denominator for diluted earnings per share   8,044,402    -    7,977,166    - 
Loss per share attributed to common shareholders basic and diluted  $(0.46)  $(7.82)  $(1.45)  $(8.83)

 

3
Table of Contents

 

Revenue Recognition

 

The Company generates its revenue from the sale of its products directly to the end user or distributor (collectively the “customer”).

 

The Company recognizes revenues by applying the following steps in accordance with FASB Accounting Standards Codification 606 “Revenue from Contracts with Customers” (“ASC 606”). Under ASC 606, revenues are recognized when control of the promised goods or services are transferred to a customer, in an amount that reflects the consideration that the Company expects to receive in exchange for those goods or services. The Company applies the following five steps in order to determine the appropriate amount of revenue to be recognized as it fulfills its obligations under each of its agreements:

 

  ● identify the contract with a customer;

 

  ● identify the performance obligations in the contract;
     
  ● determine the transaction price;
     
  ● allocate the transaction price to performance obligations in the contract; and
     
  ● recognize revenue as the performance obligation is satisfied.

 

The Company’s performance obligations are satisfied when goods or products are shipped on an FOB shipping point basis as title passes when shipped. Our product is generally paid in advance of shipment or standard net 30 days and we offer no specific right of return, refund or warranty related to our products except for cases of defective products of which there have been none to date.

 

Accounts Receivable and Credit Risk

 

Accounts receivable are generated from sales of the Company’s products. The Company provides an allowance for doubtful collections, which is based upon a review of outstanding receivables, historical collection information, and existing economic conditions. As of September 30, 2026 and December 31, 2025, the Company had not recognized an allowance for doubtful collections.

 

Inventory

 

Inventories are stated at the lower of cost or market. The Company periodically reviews the value of items in inventory and provides write-downs or write-offs of inventory based on its assessment of market conditions. Write-downs and write-offs are charged to cost of goods sold. Inventory is based upon the average cost method of accounting.

 

Fair Value of Financial Instruments

 

The fair value of our assets and liabilities, which qualify as financial instruments under ASC Topic 820, “Fair Value Measurements and Disclosures,” approximates the carrying amounts represented in the accompanying balance sheet, primarily due to their short-term nature.

 

Income Taxes

 

We account for income taxes under ASC 740 Income Taxes (“ASC 740”). ASC 740 requires the recognition of deferred tax assets and liabilities for both the expected impact of differences between the financial statement and tax basis of assets and liabilities and for the expected future tax benefit to be derived from tax loss and tax credit carry forwards. ASC 740 additionally requires a valuation allowance to be established when it is more likely than not that all or a portion of deferred tax assets will not be realized.

 

4
Table of Contents

 

ASC 740 also clarifies the accounting for uncertainty in income taxes recognized in an enterprise’s financial statements and prescribes a recognition threshold and measurement process for financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more-likely-than-not to be sustained upon examination by taxing authorities. ASC 740 also provides guidance on derecognition, classification, interest and penalties, accounting in interim period, disclosure and transition. Based on our evaluation, it has been concluded that there are no significant uncertain tax positions requiring recognition in our financial statements. Since we were incorporated on October 24, 2018, the evaluation was performed for 2018 tax year, which would be the only period subject to examination. We believe that our income tax positions and deductions would be sustained on audit and does not anticipate any adjustments that would result in a material changes to our financial position. Our policy for recording interest and penalties associated with audits is to record such items as a component of income tax expense.

 

The Company’s deferred tax asset at September 30, 2026 and December 31, 2025 consist of net operating loss carry forwards calculated using federal and state effective tax rates equating to approximately $11,112,433 and $8,919,080, respectively, less a valuation allowance in the amount of approximately $11,112,433 and $8,919,080, respectively. Due to the Company’s lack of earnings history, the deferred tax asset has been fully offset by a valuation allowance in the nine months ended September 30, 2026 and year ended December 31, 2025.

 

Research and Development

 

The Company accounts for research and development costs in accordance with the Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred. Third-party research and developments costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company-sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred research and development expenses of $300 and $15,522 for the nine-months ended September 30, 2026, and 2025, respectively.

 

Stock Based Compensation

 

We recognize compensation costs to employees under FASB Accounting Standards Codification 718 “Compensation - Stock Compensation” (“ASC 718”). Under ASC 718, companies are required to measure the compensation costs of share-based compensation arrangements based on the grant-date fair value and recognize the costs in the financial statements over the period during which employees are required to provide services. Share based compensation arrangements include stock options and warrants. As such, compensation cost is measured on the date of grant at their fair value. Such compensation amounts, if any, are amortized over the respective vesting periods of the option grant.

 

On October 24, 2018, the inception date (“Inception”), we adopted ASU No. 2018-07 “Compensation - Stock Compensation (Topic 718): Improvements to Nonemployee Share-Based Payment Accounting.” These amendments expand the scope of Topic 718, Compensation - Stock Compensation (which currently only includes share-based payments to employees) to include share-based payments issued to nonemployees for goods or services. Consequently, the accounting for share-based payments to nonemployees and employees will be substantially aligned.

 

Related parties

 

The Company follows subtopic 850-10 of the FASB Accounting Standards Codification for the identification of related parties and disclosure of related party transactions.

 

Pursuant to Section 850-10-20 the related parties include a. affiliates of the Company; b. Entities for which investments in their equity securities would be required, absent the election of the fair value option under the Fair Value Option Subsection of Section 825–10–15, to be accounted for by the equity method by the investing entity; c. trusts for the benefit of employees, such as pension and profit-sharing trusts that are managed by or under the trusteeship of management; d. principal owners of the Company; e. management of the Company; f. other parties with which the Company may deal if one party controls or can significantly influence the management or operating policies of the other to an extent that one of the transacting parties might be prevented from fully pursuing its own separate interests; and g. Other parties that can significantly influence the management or operating policies of the transacting parties or that have an ownership interest in one of the transacting parties and can significantly influence the other to an extent that one or more of the transacting parties might be prevented from fully pursuing its own separate interests.

 

5
Table of Contents

 

The consolidated financial statements shall include disclosures of material related party transactions, other than compensation arrangements, expense allowances, and other similar items in the ordinary course of business. However, disclosure of transactions that are eliminated in the preparation of consolidated or combined financial statements is not required in those statements. The disclosures shall include: a. the nature of the relationship(s) involved; b. a description of the transactions, including transactions to which no amounts or nominal amounts were ascribed, for each of the periods for which income statements are presented, and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements; c. the dollar amounts of transactions for each of the periods for which income statements are presented and the effects of any change in the method of establishing the terms from that used in the preceding period; and d. amounts due from or to related parties as of the date of each balance sheet presented and, if not otherwise apparent, the terms and manner of settlement.

 

Recent Accounting Pronouncements

 

Management does not believe that any recently issued, but not effective, accounting standards, if currently adopted, would have a material effect on our financial statements.

 

Results of Operations

 

For the three months ended September 30, 2026 and 2025

 

The following table provides selected financial data about us for the three months ended September 30, 2026 and 2025, respectively.

 

   For the Three Months Ended
September 30,
 
   2026   2025 
Sales  $692,280   $1,514,817 
Related party revenue share   186,499    509,085 
Cost of Sales   877,166    1,480,760 
Gross Profit (Loss)   1,613    543,142 
Total operating expenses   (1,626,519)   (17,215,566)
Other income (expense)   (936,320)   (16,908,792)
Net Loss  $(2,561,225)  $(33,581,216)

 

Revenues

 

We generated $692,280 in revenues from beverage and $186,499 from related party revenue share for the three months ended September 30, 2026 compared to $1,514,817 from beverage and $509,085 from related revenue share in the three months ended September 30, 2025.

 

Operating Expenses and Other Income (Expense)

 

We had total operating expenses of $1,626,519 for the three months ended September 30, 2026 compared to $17,215,566 for the three months ended September 30, 2025.

 

Operating expenses for the three months ended September 30, 2026 were in connection with our daily operations as follows: (i) marketing expenses of $120,528; (ii) research and development of $0; (iii) legal and professional expenses of $471,623, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $11,063; (v) depreciation and amortization of $164,527; (vi) general and administrative expenses of $846,866, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $11,912.

 

Other income (expense) for the three months ended September 30, 2026 included: (i) net interest income of $423; (ii) tax expense of $0; (iii) net loss on settlement of $41,114 and loss on deconsolidation of $0; (iv) realized loss on exchange of digital assets of $7,345,237; (v) unrealized gain on digital assets of $5,388,025, (vi) realized gain on receivable of $1,262,843; (vii) unrealized loss on equity investments of $207,982; (viii) impairment of promissory note of $50,000 and (ix) other income of 56,680.

 

6
Table of Contents

 

Operating expenses for the three months ended September 30, 2025 were in connection with our daily operations as follows: (i) marketing expenses of $216,145; (ii) research and development of $8,668; (iii) legal and professional expenses of $5,543,273, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $42,002; (v) depreciation and amortization of $202,237; (vi) general and administrative expenses of $1,589,038, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $9,614,203.

 

Other income for the three months ended September 30, 2025 included: (i) interest income of $72,227; (ii) interest expense of $273,711; (iii) loss on settlement of $4,278,036, (iv) gain on sale of stock of $500,000, (v) loss on exchange of $120,446, (vi) unrealized loss on digital asset of $7,213,473, and (vii) unrealized loss of equity investment of $5,595,353.

 

Income/Losses

 

Net income (losses) were $(2,561,225) and $(33,581,216) for the three months ended September 30, 2026 and 2025, respectively.

 

For the nine months ended September 30, 2026 and 2025

 

The following table provides selected financial data about us for the nine months ended September 30, 2026 and 2025, respectively.

 

   For the Nine Months Ended
September 30,
 
   2026   2025 
Sales  $2,271,548   $1,601,865 
Related party revenue share   4,107,694    509,085 
Cost of Sales   2,393,534    1,522,942 
Gross Profit (Loss)   3,985,708    588,008 
Total operating expenses   (6,271,700)   (26,990,405)
Other income (expense)   (8,158,547)   (869,193)
Net Loss  $(10,444,540)  $(25,533,204)

 

Revenues

 

We generated $2,271,548 in revenues from beverage and $4,107,694 from related party revenue share for the nine months ended September 30, 2026 compared to $1,601,865 beverage and $509,085 from related party revenue share for the nine months ended September 30, 2025.

 

Operating Expenses and Other Income (Expense)

 

We had total operating expenses of $6,271,700 for the nine months ended September 30, 2026 compared to $26,990,405 for the nine months ended September 30, 2025.

 

Operating expenses for the nine months ended September 30, 2026 were in connection with our daily operations as follows: (i) marketing expenses of $500,872; (ii) research and development of $300; (iii) legal and professional expenses of $1,978,369, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $54,803; (v) depreciation and amortization of $530,265; (vi) general and administrative expenses of $2,784,032, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $423,059.

 

Other income for the nine months ended September 30, 2026 included: (i) net interest expense of $30,565; (ii) tax expense of $47,248; (iii) gain on settlement of $377,978 and loss on deconsolidation of $53,034; (iv) gain on sale of marketable securities of $796,404; (v) realized loss on exchange of digital assets of $7,515,268; (vi) unrealized loss on digital assets of $2,779,399, (vii) realized gain on receivable of $1,262,843, (viii) net unrealized loss on equity investments of $190,539; (ix) impairment of promissory note of $50,000 and (x) other income of $70,280.

 

7
Table of Contents

 

Operating expenses for the nine months ended September 30, 2025 were in connection with our daily operations as follows: (i) marketing expenses of $1,436,194; (ii) research and development of $24,190; (iii) legal and professional expenses of $9,136,580, consisting of corporate advisory services, annual report preparation fees and general corporate governance fees; (iv) rent and utilities of $153,771; (v) depreciation and amortization of $423,822; (vi) general and administrative expenses of $3,304,536, consisting of payroll and related taxes, travel, meals and entertainment, office supplies and expense, compensation related to management transition agreements and other normal office and administration expenses; and (vii) stock based compensation of $12,511,312.

 

Other income for the nine months ended September 30, 2025 included: (i) interest income of $64,863; (ii) interest expense of $496,840; (iii) gain on sale of stock of $180,556; (iv) loss on settlement of $4,640,465, (v) gain of sale of stock of $500,000, (vi) loss on exchange of $120,446, (vii) unrealized gain on equity investment of $12,594,998, and (viii) unrealized loss on digital asset of $7,213,473.

 

Income/Losses

 

Net income (losses) were $(10,444,540) and $(25,533,204) for the nine months ended September 30, 2026 and 2025, respectively.

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

As a “smaller reporting company”, we are not required to provide the information required by this Item.

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

The Company maintains disclosure controls and procedures that are designed to ensure that information required to be disclosed in the Company’s Exchange Act reports is recorded, processed, summarized and reported within the time communicated to the Company’s management, including its Chief Executive Officer and principal financial officer, as appropriate, to allow timely decisions regarding required disclosure based closely on the definition of “disclosure controls and procedures” in Rule 13a-15(e). The Company’s disclosure controls and procedures are designed to provide a reasonable level of assurance of reaching the Company’s desired disclosure control objectives. Any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objective and management necessarily applies its judgment in evaluating the cost-benefit relationship of possible controls and procedures. The Company’s certifying officers have concluded that the Company’s disclosure controls and procedures are ineffective in reaching that level of assurance.

 

At the end of the period being reported upon, the Company carried out an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s Chief Executive Officer and Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. Based on the foregoing, our Chief Executive Officer and Chief Financial Officer concluded that our disclosure controls and procedures were ineffective to ensure that the material information required to be included in our Securities and Exchange Commission reports is accumulated and communicated to our management, including our principal executive and financial officer, recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms relating to the Company, based on the assessment and control of disclosure decisions currently performed by a small team. The Company plans to expand its management team and build a fulsome internal control framework required by a more complex entity.

 

Changes in Internal Control Over Financial Reporting

 

During the past nine months and previous fiscal year, we implemented significant measures to remediate the previously disclosed ineffectiveness of our internal control over financial reporting, which included an insufficient degree of segregation of duties amongst our accounting and financial reporting personnel, and the lack of a formalized and complete set of policy and procedure documentation evidencing our system of internal controls over financial reporting. The remediation measures consisted of the hiring of individuals with appropriate experience in internal controls over financial reporting, and the modification of our accounting processes and enhancement to our financial controls, including the testing of such controls.

 

Other than as described above, there was no change in our internal control over financial reporting (as defined in Rules 13a-15(f) or 15d-15(f) under the Exchange Act) identified in connection with the evaluation required by Rules 13a-15(d) or 15d-15(d) that occurred during the nine months ended September 30, 2026 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

The Company’s management believes that a control system, no matter how well designed and operated can provide only reasonable assurance and cannot provide absolute assurance that the objectives of the internal control system are met, and no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, within a company have been detected. Further, the design of an internal control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitation in all internal control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.

 

8
Table of Contents

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings.

 

The Company may be subject to legal proceedings and claims arising from contracts or other matters from time to time in the ordinary course of business. Except as set forth below, management is not aware of any pending or threatened litigation where the ultimate disposition or resolution could have a material adverse effect on its financial position, results of operations or liquidity.

 

On February 9, 2024, “Sabby” Volatility Warrant Master Fund Ltd. sued the Company in the federal district court for the Southern District of New York, case captioned, Sabby Volatility Warrant Master Fund Ltd. v. Safety Shot, Inc., No. 1:24-cv-920-NRB (the “Litigation”). Sabby’s initial complaint alleges that the Company has improperly refused to honor Sabby’s exercise of a Warrant to acquire 2,105,263 shares of common stock. On March 8, 2024, Sabby filed an amended complaint and the Company answered the amended complaint. Sabby seeks “liquidated and compensatory damages in an amount to be proven at trial,” including compensatory damages “estimated to be at least $750,000,” liquidated damages “estimated to be at least $600,000,” specific performance, attorneys’ fees, expenses and costs. The Company does not believe that the Litigation’s ultimate disposition or resolution will have a material adverse effect on the Company’s financial position, results of operations or liquidity. The Company has made an offer of $1.5 million to settle this matter. In January of 2026, the Company participated in a trial in the Litigation as to damages only and is awaiting the Court’s ruling. As of September 30, 2026, the Company’s cost to Sabby at the close of the litigation is $950,557.

 

Item 1A. Risk Factors

 

Not applicable as we are a smaller reporting company.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

 

During the nine months ended September 30, 2026, the Company had no unregistered shares of common stock issued.

 

Item 3. Defaults Upon Senior Securities

 

None.

 

Item 4. Mine Safety Disclosures

 

Not applicable.

 

Item 5. Other Information

 

None.

 

9
Table of Contents

 

Item 6. Exhibits

 

Exhibit

Number

  Description
     
10.1   Preferred Stock Redemption Agreement, dated September 4, 2026, by and between the Company and Core4 Capital (Incorporated by reference to Exhibit 10.1 to our Current Report on Form 8-K filed with the SEC on September 11, 2026)
31.1   Section 302 Certification by the Principal Executive Officer, filed herewith
31.2   Section 302 Certification by the Principal Financial Officer and Principal Accounting Officer, filed herewith
32.1*   Section 906 Certification by the Principal Executive Officer, filed herewith
32.2*   Section 906 Certification by the Principal Financial Officer and Principal Accounting Officer, filed herewith
101.INS   Inline XBRL Instance Document
101.SCH   Inline XBRL Taxonomy Extension Schema Document
101.CAL   Inline XBRL Taxonomy Extension Calculation Linkbase Document
101.DEF   Inline XBRL Taxonomy Extension Definition Linkbase Document
101.LAB   Inline XBRL Taxonomy Extension Label Linkbase Document
101.PRE   Inline XBRL Taxonomy Extension Presentation Linkbase Document
104   Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

 

* The certifications attached as Exhibits 32.1 and 32.2 accompany this quarterly report on Form 10-Q pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and shall not be deemed “filed” by the Registrant for purposes of Section 18 of the Securities Exchange Act of 1934, as amended.

 

10
Table of Contents

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BONK, INC.
   
Dated: November 16, 2026 /s/ Jarrett Boon
  Jarrett Boon
  Chief Executive Officer
  (Principal Executive Officer Officer)

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

  BONK, INC.
   
Dated: November 16, 2026 /s/ Markita Russell
  Markita Russell
  Chief Financial Officer
  (Principal Financial Officer Officer)

 

11

Keep reading